| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | cadmium ion binding | 6.13e-20 | 12 | 17 | 7 | GO:0046870 | |
| GeneOntologyMolecularFunction | copper ion binding | 3.11e-18 | 78 | 17 | 9 | GO:0005507 | |
| GeneOntologyMolecularFunction | zinc ion binding | 4.35e-10 | 891 | 17 | 10 | GO:0008270 | |
| GeneOntologyMolecularFunction | transition metal ion binding | 7.15e-09 | 1189 | 17 | 10 | GO:0046914 | |
| GeneOntologyBiologicalProcess | detoxification of copper ion | MT1DP MT1A MT1B MT1E MT1F MT1G MT1H MT1M MT1X MT2A MT1HL1 MT3 | 2.68e-37 | 16 | 16 | 12 | GO:0010273 |
| GeneOntologyBiologicalProcess | stress response to copper ion | MT1DP MT1A MT1B MT1E MT1F MT1G MT1H MT1M MT1X MT2A MT1HL1 MT3 | 2.68e-37 | 16 | 16 | 12 | GO:1990169 |
| GeneOntologyBiologicalProcess | stress response to metal ion | MT1DP MT1A MT1B MT1E MT1F MT1G MT1H MT1M MT1X MT2A MT1HL1 MT3 | 9.52e-35 | 22 | 16 | 12 | GO:0097501 |
| GeneOntologyBiologicalProcess | detoxification of inorganic compound | MT1DP MT1A MT1B MT1E MT1F MT1G MT1H MT1M MT1X MT2A MT1HL1 MT3 | 7.65e-34 | 25 | 16 | 12 | GO:0061687 |
| GeneOntologyBiologicalProcess | cellular response to copper ion | MT1DP MT1A MT1B MT1E MT1F MT1G MT1H MT1M MT1X MT2A MT1HL1 MT3 | 2.56e-33 | 27 | 16 | 12 | GO:0071280 |
| GeneOntologyBiologicalProcess | cellular response to zinc ion | MT1DP MT1A MT1B MT1E MT1F MT1G MT1H MT1M MT1X MT2A MT1HL1 MT3 | 4.47e-33 | 28 | 16 | 12 | GO:0071294 |
| GeneOntologyBiologicalProcess | cellular response to cadmium ion | MT1DP MT1A MT1B MT1E MT1F MT1G MT1H MT1M MT1X MT2A MT1HL1 MT3 | 2.25e-30 | 43 | 16 | 12 | GO:0071276 |
| GeneOntologyBiologicalProcess | response to copper ion | MT1DP MT1A MT1B MT1E MT1F MT1G MT1H MT1M MT1X MT2A MT1HL1 MT3 | 2.25e-30 | 43 | 16 | 12 | GO:0046688 |
| GeneOntologyBiologicalProcess | intracellular zinc ion homeostasis | MT1DP MT1A MT1B MT1E MT1F MT1G MT1H MT1M MT1X MT2A MT1HL1 MT3 | 3.09e-30 | 44 | 16 | 12 | GO:0006882 |
| GeneOntologyBiologicalProcess | response to zinc ion | MT1DP MT1A MT1B MT1E MT1F MT1G MT1H MT1M MT1X MT2A MT1HL1 MT3 | 2.55e-28 | 61 | 16 | 12 | GO:0010043 |
| GeneOntologyBiologicalProcess | response to cadmium ion | MT1DP MT1A MT1B MT1E MT1F MT1G MT1H MT1M MT1X MT2A MT1HL1 MT3 | 1.06e-27 | 68 | 16 | 12 | GO:0046686 |
| GeneOntologyBiologicalProcess | cellular response to chromate | 1.59e-26 | 8 | 16 | 8 | GO:0071247 | |
| GeneOntologyBiologicalProcess | response to chromate | 1.43e-25 | 9 | 16 | 8 | GO:0046687 | |
| GeneOntologyBiologicalProcess | detoxification | MT1DP MT1A MT1B MT1E MT1F MT1G MT1H MT1M MT1X MT2A MT1HL1 MT3 | 1.17e-22 | 170 | 16 | 12 | GO:0098754 |
| GeneOntologyBiologicalProcess | nitric oxide mediated signal transduction | 1.67e-21 | 40 | 16 | 9 | GO:0007263 | |
| GeneOntologyBiologicalProcess | cellular response to metal ion | MT1DP MT1A MT1B MT1E MT1F MT1G MT1H MT1M MT1X MT2A MT1HL1 MT3 | 2.66e-21 | 219 | 16 | 12 | GO:0071248 |
| GeneOntologyBiologicalProcess | response to toxic substance | MT1DP MT1A MT1B MT1E MT1F MT1G MT1H MT1M MT1X MT2A MT1HL1 MT3 | 7.89e-20 | 289 | 16 | 12 | GO:0009636 |
| GeneOntologyBiologicalProcess | response to metal ion | MT1DP MT1A MT1B MT1E MT1F MT1G MT1H MT1M MT1X MT2A MT1HL1 MT3 | 6.36e-18 | 415 | 16 | 12 | GO:0010038 |
| GeneOntologyBiologicalProcess | intracellular monoatomic cation homeostasis | MT1DP MT1A MT1B MT1E MT1F MT1G MT1H MT1M MT1X MT2A MT1HL1 MT3 | 6.71e-16 | 611 | 16 | 12 | GO:0030003 |
| GeneOntologyBiologicalProcess | intracellular monoatomic ion homeostasis | MT1DP MT1A MT1B MT1E MT1F MT1G MT1H MT1M MT1X MT2A MT1HL1 MT3 | 8.31e-16 | 622 | 16 | 12 | GO:0006873 |
| GeneOntologyBiologicalProcess | inorganic ion homeostasis | MT1DP MT1A MT1B MT1E MT1F MT1G MT1H MT1M MT1X MT2A MT1HL1 MT3 | 8.31e-16 | 622 | 16 | 12 | GO:0098771 |
| GeneOntologyBiologicalProcess | negative regulation of growth | 1.50e-15 | 283 | 16 | 10 | GO:0045926 | |
| GeneOntologyBiologicalProcess | monoatomic cation homeostasis | MT1DP MT1A MT1B MT1E MT1F MT1G MT1H MT1M MT1X MT2A MT1HL1 MT3 | 3.72e-15 | 705 | 16 | 12 | GO:0055080 |
| GeneOntologyBiologicalProcess | monoatomic ion homeostasis | MT1DP MT1A MT1B MT1E MT1F MT1G MT1H MT1M MT1X MT2A MT1HL1 MT3 | 4.56e-15 | 717 | 16 | 12 | GO:0050801 |
| GeneOntologyBiologicalProcess | negative regulation of neuron apoptotic process | 3.08e-14 | 236 | 16 | 9 | GO:0043524 | |
| GeneOntologyBiologicalProcess | intracellular chemical homeostasis | MT1DP MT1A MT1B MT1E MT1F MT1G MT1H MT1M MT1X MT2A MT1HL1 MT3 | 4.34e-14 | 866 | 16 | 12 | GO:0055082 |
| GeneOntologyBiologicalProcess | cellular homeostasis | MT1DP MT1A MT1B MT1E MT1F MT1G MT1H MT1M MT1X MT2A MT1HL1 MT3 | 1.91e-13 | 981 | 16 | 12 | GO:0019725 |
| GeneOntologyBiologicalProcess | regulation of neuron apoptotic process | 1.23e-12 | 355 | 16 | 9 | GO:0043523 | |
| GeneOntologyBiologicalProcess | chemical homeostasis | MT1DP MT1A MT1B MT1E MT1F MT1G MT1H MT1M MT1X MT2A MT1HL1 MT3 | 3.35e-12 | 1249 | 16 | 12 | GO:0048878 |
| GeneOntologyBiologicalProcess | neuron apoptotic process | 4.80e-12 | 413 | 16 | 9 | GO:0051402 | |
| GeneOntologyBiologicalProcess | regulation of growth | 3.55e-11 | 777 | 16 | 10 | GO:0040008 | |
| GeneOntologyBiologicalProcess | growth | 3.29e-09 | 1235 | 16 | 10 | GO:0040007 | |
| GeneOntologyBiologicalProcess | negative regulation of apoptotic process | 3.56e-08 | 1133 | 16 | 9 | GO:0043066 | |
| GeneOntologyBiologicalProcess | negative regulation of programmed cell death | 4.73e-08 | 1171 | 16 | 9 | GO:0043069 | |
| GeneOntologyBiologicalProcess | cellular response to oxygen-containing compound | 2.98e-07 | 1450 | 16 | 9 | GO:1901701 | |
| GeneOntologyCellularComponent | lytic vacuole | 8.83e-08 | 811 | 17 | 8 | GO:0000323 | |
| GeneOntologyCellularComponent | lysosome | 8.83e-08 | 811 | 17 | 8 | GO:0005764 | |
| GeneOntologyCellularComponent | vacuole | 2.20e-07 | 913 | 17 | 8 | GO:0005773 | |
| GeneOntologyCellularComponent | intermediate filament | 8.04e-07 | 227 | 17 | 5 | GO:0005882 | |
| GeneOntologyCellularComponent | intermediate filament cytoskeleton | 1.66e-06 | 263 | 17 | 5 | GO:0045111 | |
| GeneOntologyCellularComponent | polymeric cytoskeletal fiber | 5.12e-05 | 899 | 17 | 6 | GO:0099513 | |
| GeneOntologyCellularComponent | supramolecular fiber | 2.29e-04 | 1179 | 17 | 6 | GO:0099512 | |
| GeneOntologyCellularComponent | supramolecular polymer | 2.38e-04 | 1187 | 17 | 6 | GO:0099081 | |
| GeneOntologyCellularComponent | keratin filament | 2.77e-03 | 97 | 17 | 2 | GO:0045095 | |
| Domain | Metalthion_vert | MT1A MT1B MT1E MT1F MT1G MT1H MT1M MT1L MT1X MT2A MT1HL1 MT3 | 4.50e-37 | 14 | 18 | 12 | IPR000006 |
| Domain | Metalthion | MT1A MT1B MT1E MT1F MT1G MT1H MT1M MT1L MT1X MT2A MT1HL1 MT3 | 4.50e-37 | 14 | 18 | 12 | IPR003019 |
| Domain | Metallothio | MT1A MT1B MT1E MT1F MT1G MT1H MT1M MT1L MT1X MT2A MT1HL1 MT3 | 4.50e-37 | 14 | 18 | 12 | PF00131 |
| Domain | Metalthion_dom_vert | 1.58e-34 | 12 | 18 | 11 | IPR023587 | |
| Domain | Metalthion_dom | 1.58e-34 | 12 | 18 | 11 | IPR017854 | |
| Domain | - | 1.58e-34 | 12 | 18 | 11 | 4.10.10.10 | |
| Domain | METALLOTHIONEIN_VRT | 1.03e-33 | 13 | 18 | 11 | PS00203 | |
| Domain | Metalthion_vert_metal_BS | 3.08e-32 | 10 | 18 | 10 | IPR018064 | |
| Domain | KAP | 1.24e-11 | 58 | 18 | 6 | IPR002494 | |
| Domain | Keratin_B2 | 5.40e-08 | 40 | 18 | 4 | PF01500 | |
| Domain | Keratin_B2_2 | 6.72e-06 | 39 | 18 | 3 | PF13885 | |
| Domain | WAP_dom | 2.00e-04 | 22 | 18 | 2 | IPR008197 | |
| Pathway | REACTOME_METALLOTHIONEINS_BIND_METALS | 2.51e-30 | 11 | 17 | 10 | M27543 | |
| Pathway | REACTOME_RESPONSE_TO_METAL_IONS | 2.28e-28 | 14 | 17 | 10 | M27541 | |
| Pathway | WP_ZINC_HOMEOSTASIS | 9.61e-26 | 37 | 17 | 11 | M39377 | |
| Pathway | WP_COPPER_HOMEOSTASIS | 4.37e-21 | 53 | 17 | 10 | M39349 | |
| Pathway | WP_OXIDATIVE_STRESS_RESPONSE | 1.88e-17 | 36 | 17 | 8 | MM15941 | |
| Pathway | WP_LUNG_FIBROSIS | 1.85e-10 | 73 | 17 | 6 | MM15827 | |
| Pathway | REACTOME_CELLULAR_RESPONSES_TO_STIMULI | 6.18e-09 | 828 | 17 | 10 | M27827 | |
| Pathway | REACTOME_KERATINIZATION | 1.33e-07 | 217 | 17 | 6 | M27640 | |
| Pathway | REACTOME_CELLULAR_RESPONSES_TO_STIMULI | 1.03e-06 | 505 | 17 | 7 | MM15548 | |
| Pathway | REACTOME_KERATINIZATION | 2.84e-05 | 153 | 17 | 4 | MM15343 | |
| Pathway | REACTOME_DEVELOPMENTAL_BIOLOGY | 2.61e-03 | 502 | 17 | 4 | MM14537 | |
| Pathway | REACTOME_DEVELOPMENTAL_BIOLOGY | 5.02e-03 | 1432 | 17 | 6 | M509 | |
| Pubmed | Role of metallothionein-III following central nervous system damage. | 1.30e-34 | 10 | 19 | 10 | 12758064 | |
| Pubmed | Role of metallothioneins in peripheral nerve function and regeneration. | 1.30e-34 | 10 | 19 | 10 | 12861386 | |
| Pubmed | 1.30e-34 | 10 | 19 | 10 | 8600611 | ||
| Pubmed | Constitutive expression of metallothionein genes in mouse brain. | 1.30e-34 | 10 | 19 | 10 | 7878670 | |
| Pubmed | Resistance of metallothionein-III null mice to cadmium-induced acute hepatotoxicity. | 1.30e-34 | 10 | 19 | 10 | 20371971 | |
| Pubmed | 1.30e-34 | 10 | 19 | 10 | 20544854 | ||
| Pubmed | 1.30e-34 | 10 | 19 | 10 | 12388585 | ||
| Pubmed | 1.43e-33 | 11 | 19 | 10 | 8003488 | ||
| Pubmed | 8.55e-33 | 12 | 19 | 10 | 34867993 | ||
| Pubmed | 4.51e-31 | 9 | 19 | 9 | 22363575 | ||
| Pubmed | 4.51e-31 | 9 | 19 | 9 | 1779826 | ||
| Pubmed | 4.51e-31 | 9 | 19 | 9 | 16049321 | ||
| Pubmed | 4.51e-31 | 9 | 19 | 9 | 16432836 | ||
| Pubmed | 4.51e-31 | 9 | 19 | 9 | 30557628 | ||
| Pubmed | 4.51e-31 | 9 | 19 | 9 | 10505629 | ||
| Pubmed | Down-regulation of metallothionein 1 and 2 after exposure to electromagnetic field in mouse testis. | 4.51e-31 | 9 | 19 | 9 | 22395140 | |
| Pubmed | 4.51e-31 | 9 | 19 | 9 | 11850030 | ||
| Pubmed | Blockade of Metallothioneins 1 and 2 Increases Skeletal Muscle Mass and Strength. | 4.51e-31 | 9 | 19 | 9 | 27956698 | |
| Pubmed | Regulation, linkage, and sequence of mouse metallothionein I and II genes. | 4.51e-31 | 9 | 19 | 9 | 6095054 | |
| Pubmed | 4.51e-31 | 9 | 19 | 9 | 28426713 | ||
| Pubmed | 4.51e-31 | 9 | 19 | 9 | 18449439 | ||
| Pubmed | Metallothionein modulates the carcinogenicity of N-butyl-N-(4-hydroxybutyl)nitrosamine in mice. | 4.51e-31 | 9 | 19 | 9 | 10426817 | |
| Pubmed | 4.51e-31 | 9 | 19 | 9 | 15735556 | ||
| Pubmed | Atrophy of large myelinated axons in metallothionein-I, II knockout mice. | 4.51e-31 | 9 | 19 | 9 | 16133945 | |
| Pubmed | 4.51e-31 | 9 | 19 | 9 | 21913972 | ||
| Pubmed | 4.51e-31 | 9 | 19 | 9 | 15979673 | ||
| Pubmed | 4.51e-31 | 9 | 19 | 9 | 15306638 | ||
| Pubmed | Cytoprotection by metallothionein against gastroduodenal mucosal injury caused by ethanol in mice. | 4.51e-31 | 9 | 19 | 9 | 10744072 | |
| Pubmed | 4.51e-31 | 9 | 19 | 9 | 9176863 | ||
| Pubmed | Metallothionein deficiency aggravates depleted uranium-induced nephrotoxicity. | 4.51e-31 | 9 | 19 | 9 | 26148447 | |
| Pubmed | 4.51e-31 | 9 | 19 | 9 | 2019319 | ||
| Pubmed | 4.51e-31 | 9 | 19 | 9 | 26267326 | ||
| Pubmed | 4.51e-31 | 9 | 19 | 9 | 19837066 | ||
| Pubmed | Zinc treatment prevents lipopolysaccharide-induced teratogenicity in mice. | 4.51e-31 | 9 | 19 | 9 | 12854659 | |
| Pubmed | Cadmium modulates adipocyte functions in metallothionein-null mice. | 4.51e-31 | 9 | 19 | 9 | 23921151 | |
| Pubmed | 4.51e-31 | 9 | 19 | 9 | 21359432 | ||
| Pubmed | 4.51e-31 | 9 | 19 | 9 | 25761970 | ||
| Pubmed | 4.51e-31 | 9 | 19 | 9 | 11792622 | ||
| Pubmed | Metallothionein-null mice express altered genes during development. | 4.51e-31 | 9 | 19 | 9 | 10753647 | |
| Pubmed | 4.51e-31 | 9 | 19 | 9 | 16150881 | ||
| Pubmed | 4.51e-31 | 9 | 19 | 9 | 10764993 | ||
| Pubmed | Metallothionein-1+2 protect the CNS after a focal brain injury. | 4.51e-31 | 9 | 19 | 9 | 11771944 | |
| Pubmed | Augmented humoral immune function in metallothionein-null mice. | 4.51e-31 | 9 | 19 | 9 | 10906280 | |
| Pubmed | 4.51e-31 | 9 | 19 | 9 | 19828842 | ||
| Pubmed | Development of a compartmental model of zinc kinetics in mice. | 4.51e-31 | 9 | 19 | 9 | 18936212 | |
| Pubmed | Metallothionein, an endogenous antioxidant, protects against retinal neuron damage in mice. | 4.51e-31 | 9 | 19 | 9 | 16936113 | |
| Pubmed | 4.51e-31 | 9 | 19 | 9 | 10947810 | ||
| Pubmed | 4.51e-31 | 9 | 19 | 9 | 11585628 | ||
| Pubmed | Epidermal proliferation of the skin in metallothionein-null mice. | 4.51e-31 | 9 | 19 | 9 | 9506445 | |
| Pubmed | 4.51e-31 | 9 | 19 | 9 | 12130647 | ||
| Pubmed | 4.51e-31 | 9 | 19 | 9 | 19254786 | ||
| Pubmed | 4.51e-31 | 9 | 19 | 9 | 11950277 | ||
| Pubmed | Decreased neurofilament density in large myelinated axons of metallothionein-I, II knockout mice. | 4.51e-31 | 9 | 19 | 9 | 16600496 | |
| Pubmed | 4.51e-31 | 9 | 19 | 9 | 18083145 | ||
| Pubmed | 4.51e-31 | 9 | 19 | 9 | 17031522 | ||
| Pubmed | 4.51e-31 | 9 | 19 | 9 | 35454172 | ||
| Pubmed | 4.51e-31 | 9 | 19 | 9 | 10788577 | ||
| Pubmed | Metallothionein-null mice exhibit reduced tolerance to ultraviolet B injury in vivo. | 4.51e-31 | 9 | 19 | 9 | 14723724 | |
| Pubmed | Metallothionein regulates intracellular zinc signaling during CD4(+) T cell activation. | 4.51e-31 | 9 | 19 | 9 | 27251638 | |
| Pubmed | Metallothionein (MT)-null mice are sensitive to cisplatin-induced hepatotoxicity. | 4.51e-31 | 9 | 19 | 9 | 9512723 | |
| Pubmed | Metallothionein-I/II null mice are sensitive to chronic oral cadmium-induced nephrotoxicity. | 4.51e-31 | 9 | 19 | 9 | 10966523 | |
| Pubmed | Trace metal, acute phase and metabolic response to endotoxin in metallothionein-null mice. | 4.51e-31 | 9 | 19 | 9 | 8615771 | |
| Pubmed | Mercury-induced cognitive impairment in metallothionein-1/2 null mice. | 4.51e-31 | 9 | 19 | 9 | 18226494 | |
| Pubmed | Metallothionein expression and neurocognitive function in mice. | 4.51e-31 | 9 | 19 | 9 | 16430929 | |
| Pubmed | Protective effects of metallothionein on isoniazid and rifampicin-induced hepatotoxicity in mice. | 4.51e-31 | 9 | 19 | 9 | 23967274 | |
| Pubmed | 4.51e-31 | 9 | 19 | 9 | 12613667 | ||
| Pubmed | Distribution and retention of mercury in metallothionen-null mice after exposure to mercury vapor. | 4.51e-31 | 9 | 19 | 9 | 10614694 | |
| Pubmed | 4.51e-31 | 9 | 19 | 9 | 18579766 | ||
| Pubmed | 4.51e-31 | 9 | 19 | 9 | 20798270 | ||
| Pubmed | Using MT(-/-) mice to study metallothionein and oxidative stress. | 4.51e-31 | 9 | 19 | 9 | 10699757 | |
| Pubmed | 4.51e-31 | 9 | 19 | 9 | 10495773 | ||
| Pubmed | 4.51e-31 | 9 | 19 | 9 | 23467591 | ||
| Pubmed | Cadmium-induced mRNA expression of Hsp32 is augmented in metallothionein-I and -II knock-out mice. | 4.51e-31 | 9 | 19 | 9 | 11051100 | |
| Pubmed | Mammalian MT1 and MT2 metallothioneins differ in their metal binding abilities. | 4.51e-31 | 9 | 19 | 9 | 23925449 | |
| Pubmed | Metallothionein 1+2 protect the CNS during neuroglial degeneration induced by 6-aminonicotinamide. | 4.51e-31 | 9 | 19 | 9 | 11835189 | |
| Pubmed | Infection of metallothionein 1+2 knockout mice with Rocky Mountain Laboratory scrapie. | 4.51e-31 | 9 | 19 | 9 | 18221736 | |
| Pubmed | Targeted disruption of metallothionein I and II genes increases sensitivity to cadmium. | 4.51e-31 | 9 | 19 | 9 | 8290567 | |
| Pubmed | 4.51e-31 | 9 | 19 | 9 | 27403038 | ||
| Pubmed | 4.51e-31 | 9 | 19 | 9 | 15639482 | ||
| Pubmed | 4.51e-31 | 9 | 19 | 9 | 15161632 | ||
| Pubmed | Role of metallothioneins as danger signals in the pathogenesis of colitis. | 4.51e-31 | 9 | 19 | 9 | 24452846 | |
| Pubmed | Metallothionein-I/II knockout mice are sensitive to acetaminophen-induced hepatotoxicity. | 4.51e-31 | 9 | 19 | 9 | 10087053 | |
| Pubmed | Deficiency of metallothionein-1 and -2 genes shortens the lifespan of the 129/Sv mouse strain. | 4.51e-31 | 9 | 19 | 9 | 25871729 | |
| Pubmed | 4.51e-31 | 9 | 19 | 9 | 18239062 | ||
| Pubmed | CNS wound healing is severely depressed in metallothionein I- and II-deficient mice. | 4.51e-31 | 9 | 19 | 9 | 10087067 | |
| Pubmed | Impaired hepatic regeneration in metallothionein-I/II knockout mice after partial hepatectomy. | 4.51e-31 | 9 | 19 | 9 | 15618127 | |
| Pubmed | 4.51e-31 | 9 | 19 | 9 | 8619230 | ||
| Pubmed | Distribution and retention of cadmium in metallothionein I and II null mice. | 4.51e-31 | 9 | 19 | 9 | 8619234 | |
| Pubmed | 4.51e-31 | 9 | 19 | 9 | 8914622 | ||
| Pubmed | Obesity and hyperleptinemia in metallothionein (-I and -II) null mice. | 4.51e-31 | 9 | 19 | 9 | 9419380 | |
| Pubmed | Helicobacter-induced gastritis in mice not expressing metallothionein-I and II. | 4.51e-31 | 9 | 19 | 9 | 14536000 | |
| Pubmed | 4.51e-31 | 9 | 19 | 9 | 14499492 | ||
| Pubmed | 4.51e-31 | 9 | 19 | 9 | 10828279 | ||
| Pubmed | 4.51e-31 | 9 | 19 | 9 | 10736338 | ||
| Pubmed | 4.51e-31 | 9 | 19 | 9 | 17409522 | ||
| Pubmed | Chemical modulation of metallothionein I and III mRNA in mouse brain. | 4.51e-31 | 9 | 19 | 9 | 7655347 | |
| Pubmed | 4.51e-31 | 9 | 19 | 9 | 22152221 | ||
| Pubmed | Gene expression profiles in the liver and kidney of metallothionein-null mice. | 4.51e-31 | 9 | 19 | 9 | 15913548 | |
| Pubmed | 4.51e-31 | 9 | 19 | 9 | 16387980 | ||
| Pubmed | 4.51e-31 | 9 | 19 | 9 | 20144643 | ||
| Interaction | SMCP interactions | 6.70e-09 | 79 | 18 | 5 | int:SMCP | |
| Interaction | MT1M interactions | 4.84e-07 | 18 | 18 | 3 | int:MT1M | |
| Interaction | SPINK7 interactions | 5.75e-07 | 19 | 18 | 3 | int:SPINK7 | |
| Interaction | KRTAP17-1 interactions | 1.01e-05 | 48 | 18 | 3 | int:KRTAP17-1 | |
| Interaction | MT1E interactions | 1.58e-05 | 7 | 18 | 2 | int:MT1E | |
| Interaction | KRTAP5-2 interactions | 2.19e-05 | 62 | 18 | 3 | int:KRTAP5-2 | |
| Interaction | CRCT1 interactions | 2.64e-05 | 66 | 18 | 3 | int:CRCT1 | |
| Interaction | LCE1E interactions | 2.89e-05 | 68 | 18 | 3 | int:LCE1E | |
| Interaction | SHBG interactions | 3.02e-05 | 69 | 18 | 3 | int:SHBG | |
| Interaction | LCE3A interactions | 4.04e-05 | 76 | 18 | 3 | int:LCE3A | |
| Interaction | KRTAP5-1 interactions | 5.84e-05 | 13 | 18 | 2 | int:KRTAP5-1 | |
| Interaction | KRTAP10-6 interactions | 6.26e-05 | 88 | 18 | 3 | int:KRTAP10-6 | |
| Interaction | LCE5A interactions | 6.69e-05 | 90 | 18 | 3 | int:LCE5A | |
| Interaction | LELP1 interactions | 1.02e-04 | 17 | 18 | 2 | int:LELP1 | |
| Interaction | MT1G interactions | 1.28e-04 | 19 | 18 | 2 | int:MT1G | |
| Interaction | CATSPER1 interactions | 1.82e-04 | 126 | 18 | 3 | int:CATSPER1 | |
| Interaction | KRTAP9-2 interactions | 2.98e-04 | 149 | 18 | 3 | int:KRTAP9-2 | |
| Interaction | OTX1 interactions | 3.35e-04 | 155 | 18 | 3 | int:OTX1 | |
| Interaction | RNF181 interactions | 3.67e-04 | 160 | 18 | 3 | int:RNF181 | |
| Interaction | KRTAP10-5 interactions | 3.67e-04 | 160 | 18 | 3 | int:KRTAP10-5 | |
| Interaction | GLRX3 interactions | 6.16e-04 | 191 | 18 | 3 | int:GLRX3 | |
| Interaction | KRTAP5-9 interactions | 7.35e-04 | 203 | 18 | 3 | int:KRTAP5-9 | |
| Interaction | LCE3B interactions | 7.62e-04 | 46 | 18 | 2 | int:LCE3B | |
| Interaction | KRTAP1-5 interactions | 8.29e-04 | 48 | 18 | 2 | int:KRTAP1-5 | |
| Interaction | RGS17 interactions | 8.29e-04 | 48 | 18 | 2 | int:RGS17 | |
| Interaction | KRTAP1-1 interactions | 9.16e-04 | 219 | 18 | 3 | int:KRTAP1-1 | |
| Interaction | FBXO34 interactions | 1.09e-03 | 55 | 18 | 2 | int:FBXO34 | |
| Interaction | KRTAP10-9 interactions | 1.21e-03 | 241 | 18 | 3 | int:KRTAP10-9 | |
| Interaction | LCE3E interactions | 1.29e-03 | 60 | 18 | 2 | int:LCE3E | |
| Interaction | KRTAP5-4 interactions | 1.42e-03 | 63 | 18 | 2 | int:KRTAP5-4 | |
| Interaction | KRTAP5-3 interactions | 1.56e-03 | 66 | 18 | 2 | int:KRTAP5-3 | |
| Interaction | LCE3C interactions | 1.61e-03 | 67 | 18 | 2 | int:LCE3C | |
| Interaction | NR4A3 interactions | 1.71e-03 | 69 | 18 | 2 | int:NR4A3 | |
| Interaction | LCE1D interactions | 1.76e-03 | 70 | 18 | 2 | int:LCE1D | |
| Interaction | LCE3D interactions | 1.91e-03 | 73 | 18 | 2 | int:LCE3D | |
| Interaction | LCE2D interactions | 1.96e-03 | 74 | 18 | 2 | int:LCE2D | |
| Interaction | LCE1C interactions | 2.12e-03 | 77 | 18 | 2 | int:LCE1C | |
| Interaction | LCE4A interactions | 2.28e-03 | 80 | 18 | 2 | int:LCE4A | |
| Interaction | KRTAP15-1 interactions | 2.34e-03 | 81 | 18 | 2 | int:KRTAP15-1 | |
| Interaction | KRTAP4-4 interactions | 2.34e-03 | 81 | 18 | 2 | int:KRTAP4-4 | |
| Interaction | LCE2B interactions | 2.34e-03 | 81 | 18 | 2 | int:LCE2B | |
| Interaction | POU4F2 interactions | 2.46e-03 | 83 | 18 | 2 | int:POU4F2 | |
| Interaction | LCE1A interactions | 2.52e-03 | 84 | 18 | 2 | int:LCE1A | |
| Interaction | LCE1B interactions | 2.57e-03 | 85 | 18 | 2 | int:LCE1B | |
| Interaction | LCE2C interactions | 2.76e-03 | 88 | 18 | 2 | int:LCE2C | |
| Interaction | MEOX2 interactions | 2.95e-03 | 697 | 18 | 4 | int:MEOX2 | |
| Interaction | KRTAP4-11 interactions | 3.01e-03 | 92 | 18 | 2 | int:KRTAP4-11 | |
| Interaction | LCE1F interactions | 3.01e-03 | 92 | 18 | 2 | int:LCE1F | |
| Interaction | KRTAP5-6 interactions | 3.14e-03 | 94 | 18 | 2 | int:KRTAP5-6 | |
| Interaction | FAM76B interactions | 3.47e-03 | 99 | 18 | 2 | int:FAM76B | |
| Interaction | KRTAP9-8 interactions | 3.54e-03 | 100 | 18 | 2 | int:KRTAP9-8 | |
| Interaction | HOXA1 interactions | 3.66e-03 | 356 | 18 | 3 | int:HOXA1 | |
| Interaction | KRTAP11-1 interactions | 4.12e-03 | 108 | 18 | 2 | int:KRTAP11-1 | |
| Interaction | NOTCH2NLA interactions | 4.43e-03 | 381 | 18 | 3 | int:NOTCH2NLA | |
| Interaction | KRTAP10-8 interactions | 5.11e-03 | 401 | 18 | 3 | int:KRTAP10-8 | |
| Interaction | KRTAP4-2 interactions | 6.08e-03 | 132 | 18 | 2 | int:KRTAP4-2 | |
| Interaction | KRTAP9-3 interactions | 6.82e-03 | 140 | 18 | 2 | int:KRTAP9-3 | |
| Interaction | SPRY2 interactions | 7.99e-03 | 152 | 18 | 2 | int:SPRY2 | |
| Interaction | KRTAP10-1 interactions | 8.09e-03 | 153 | 18 | 2 | int:KRTAP10-1 | |
| Interaction | CREB5 interactions | 9.24e-03 | 164 | 18 | 2 | int:CREB5 | |
| Interaction | CYSRT1 interactions | 9.96e-03 | 511 | 18 | 3 | int:CYSRT1 | |
| Interaction | KRTAP1-3 interactions | 1.15e-02 | 184 | 18 | 2 | int:KRTAP1-3 | |
| Interaction | ADAMTSL4 interactions | 1.58e-02 | 217 | 18 | 2 | int:ADAMTSL4 | |
| Cytoband | 16q13 | 3.44e-34 | 36 | 19 | 12 | 16q13 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr16q13 | 1.53e-33 | 40 | 19 | 12 | chr16q13 | |
| Cytoband | 17q21.2 | 3.85e-04 | 70 | 19 | 2 | 17q21.2 | |
| Cytoband | 11p15.5 | 1.09e-03 | 118 | 19 | 2 | 11p15.5 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr17q21 | 1.61e-02 | 473 | 19 | 2 | chr17q21 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr11p15 | 2.24e-02 | 564 | 19 | 2 | chr11p15 | |
| GeneFamily | Metallothioneins | MT1DP MT1A MT1B MT1E MT1F MT1G MT1H MT1M MT1L MT1X MT2A MT1HL1 MT3 | 2.08e-37 | 19 | 19 | 13 | 638 |
| GeneFamily | Keratin associated proteins | 1.06e-09 | 109 | 19 | 6 | 619 | |
| Coexpression | RICHERT_PBMC_HIV_LIPO_5_AGE_37_48YO_STIMULATED_VS_UNSTIMULATED_0W_14W_METALLOTHIONEIN_SUBSET_UP | 1.37e-26 | 8 | 19 | 8 | M41082 | |
| Coexpression | IGLESIAS_E2F_TARGETS_DN | 2.68e-23 | 27 | 19 | 9 | MM643 | |
| Coexpression | HOUSTIS_ROS | 4.03e-21 | 44 | 19 | 9 | MM1142 | |
| Coexpression | VANDESLUIS_COMMD1_TARGETS_GROUP_2_UP | 4.36e-21 | 22 | 19 | 8 | MM1299 | |
| Coexpression | SCHLINGEMANN_SKIN_CARCINOGENESIS_TPA_UP | 9.51e-21 | 48 | 19 | 9 | MM649 | |
| Coexpression | PIONTEK_PKD1_TARGETS_UP | 1.72e-20 | 51 | 19 | 9 | MM794 | |
| Coexpression | BERENJENO_TRANSFORMED_BY_RHOA_FOREVER_UP | 4.22e-20 | 28 | 19 | 8 | MM487 | |
| Coexpression | GUILLAUMOND_KLF10_TARGETS_UP | 7.10e-20 | 59 | 19 | 9 | MM952 | |
| Coexpression | ZHENG_RESPONSE_TO_ARSENITE_UP | 1.92e-19 | 15 | 19 | 7 | M1589 | |
| Coexpression | BRACHAT_RESPONSE_TO_METHOTREXATE_DN | 6.62e-19 | 38 | 19 | 8 | MM1161 | |
| Coexpression | MA_MYELOID_DIFFERENTIATION_UP | 3.52e-18 | 46 | 19 | 8 | MM640 | |
| Coexpression | BOYLAN_MULTIPLE_MYELOMA_PCA3_UP | 5.37e-18 | 93 | 19 | 9 | MM850 | |
| Coexpression | ZHANG_UTERUS_C2_REGENERATIVE_UP | 7.97e-18 | 97 | 19 | 9 | MM16605 | |
| Coexpression | HEVNER_CORTEX_CAUDAL_VENTRICULAR_ZONE | 1.01e-17 | 52 | 19 | 8 | MM442 | |
| Coexpression | WANG_TARGETS_OF_MLL_CBP_FUSION_UP | 1.01e-17 | 52 | 19 | 8 | MM628 | |
| Coexpression | HUMMERICH_SKIN_CANCER_PROGRESSION_UP | 1.06e-17 | 100 | 19 | 9 | MM514 | |
| Coexpression | BRACHAT_RESPONSE_TO_CAMPTOTHECIN_DN | 1.40e-17 | 54 | 19 | 8 | MM1195 | |
| Coexpression | LEIN_ASTROCYTE_MARKERS | 1.40e-17 | 54 | 19 | 8 | MM715 | |
| Coexpression | JIANG_AGING_HYPOTHALAMUS_UP | 2.58e-17 | 58 | 19 | 8 | MM703 | |
| Coexpression | LUDWICZEK_TREATING_IRON_OVERLOAD | 5.56e-17 | 12 | 19 | 6 | MM792 | |
| Coexpression | TABULA_MURIS_SENIS_HEART_AND_AORTA_CARDIOMYOCYTE_AGEING | 9.09e-17 | 126 | 19 | 9 | MM3711 | |
| Coexpression | MA_RAT_AGING_UP | 9.78e-17 | 127 | 19 | 9 | MM16096 | |
| Coexpression | TABULA_MURIS_SENIS_LIMB_MUSCLE_SKELETAL_MUSCLE_SATELLITE_CELL_AGEING | 1.84e-16 | 136 | 19 | 9 | MM3747 | |
| Coexpression | BERENJENO_TRANSFORMED_BY_RHOA_REVERSIBLY_UP | 4.81e-16 | 16 | 19 | 6 | MM1089 | |
| Coexpression | YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_7 | 5.80e-16 | 84 | 19 | 8 | MM873 | |
| Coexpression | ICHIBA_GRAFT_VERSUS_HOST_DISEASE_35D_UP | 1.97e-15 | 176 | 19 | 9 | MM1048 | |
| Coexpression | MARTORIATI_MDM4_TARGETS_NEUROEPITHELIUM_UP | 3.11e-15 | 185 | 19 | 9 | MM1115 | |
| Coexpression | TABULA_MURIS_SENIS_LIMB_MUSCLE_MESENCHYMAL_STEM_CELL_AGEING | 5.26e-15 | 196 | 19 | 9 | MM3746 | |
| Coexpression | SARTIPY_BLUNTED_BY_INSULIN_RESISTANCE_UP | 6.04e-15 | 23 | 19 | 6 | MM1198 | |
| Coexpression | TABULA_MURIS_SENIS_PANCREAS_PANCREATIC_BETA_CELL_AGEING | 1.08e-14 | 212 | 19 | 9 | MM3816 | |
| Coexpression | PASINI_SUZ12_TARGETS_UP | 1.54e-14 | 125 | 19 | 8 | MM1065 | |
| Coexpression | NAKAMURA_ADIPOGENESIS_EARLY_UP | 1.62e-14 | 63 | 19 | 7 | M2024 | |
| Coexpression | TABULA_MURIS_SENIS_SPLEEN_MACROPHAGE_AGEING | 1.87e-14 | 128 | 19 | 8 | MM3838 | |
| Coexpression | TUOMISTO_TUMOR_SUPPRESSION_BY_COL13A1_UP | 2.25e-14 | 28 | 19 | 6 | MM707 | |
| Coexpression | GROSS_HYPOXIA_VIA_HIF1A_DN | 2.26e-14 | 131 | 19 | 8 | MM1127 | |
| Coexpression | YAMAZAKI_TCEB3_TARGETS_DN | 2.44e-14 | 232 | 19 | 9 | MM1019 | |
| Coexpression | ICHIBA_GRAFT_VERSUS_HOST_DISEASE_D7_UP | 3.46e-14 | 138 | 19 | 8 | MM1047 | |
| Coexpression | MARKEY_RB1_ACUTE_LOF_DN | 8.72e-14 | 267 | 19 | 9 | MM1091 | |
| Coexpression | TABULA_MURIS_SENIS_DIAPHRAGM_SKELETAL_MUSCLE_SATELLITE_CELL_AGEING | 9.65e-14 | 270 | 19 | 9 | MM3696 | |
| Coexpression | DESCARTES_FETAL_PANCREAS_ACINAR_CELLS | 2.16e-13 | 90 | 19 | 7 | M40267 | |
| Coexpression | PASQUALUCCI_LYMPHOMA_BY_GC_STAGE_UP | 2.28e-13 | 297 | 19 | 9 | MM1003 | |
| Coexpression | DARWICHE_PAPILLOMA_RISK_HIGH_UP | 2.39e-13 | 175 | 19 | 8 | MM499 | |
| Coexpression | DARWICHE_SQUAMOUS_CELL_CARCINOMA_UP | 2.39e-13 | 175 | 19 | 8 | MM501 | |
| Coexpression | BUSSLINGER_DUODENAL_BCHE_CELLS | 3.62e-13 | 43 | 19 | 6 | M40032 | |
| Coexpression | TABULA_MURIS_SENIS_MAMMARY_GLAND_B_CELL_AGEING | 3.88e-13 | 315 | 19 | 9 | MM3784 | |
| Coexpression | DARWICHE_PAPILLOMA_RISK_LOW_DN | 3.91e-13 | 186 | 19 | 8 | MM498 | |
| Coexpression | FOSTER_KDM1A_TARGETS_UP | 4.11e-13 | 317 | 19 | 9 | MM956 | |
| Coexpression | TABULA_MURIS_SENIS_HEART_AND_AORTA_FIBROBLAST_OF_CARDIAC_TISSUE_AGEING | 5.43e-13 | 327 | 19 | 9 | MM3714 | |
| Coexpression | TABULA_MURIS_SENIS_BLADDER_BLADDER_CELL_AGEING | 6.22e-13 | 332 | 19 | 9 | MM3679 | |
| Coexpression | GSE41176_UNSTIM_VS_ANTI_IGM_STIM_TAK1_KO_BCELL_24H_DN | 6.74e-13 | 199 | 19 | 8 | M9920 | |
| Coexpression | GSE42088_UNINF_VS_LEISHMANIA_INF_DC_8H_UP | 7.02e-13 | 200 | 19 | 8 | M9909 | |
| Coexpression | ZENG_GU_POST_ICB_METAGENE_22 | 1.08e-12 | 211 | 19 | 8 | MM17089 | |
| Coexpression | LE_EGR2_TARGETS_DN | 1.42e-12 | 117 | 19 | 7 | MM1139 | |
| Coexpression | AMUNDSON_RESPONSE_TO_ARSENITE | 1.46e-12 | 219 | 19 | 8 | M262 | |
| Coexpression | SUNG_METASTASIS_STROMA_DN | 1.53e-12 | 54 | 19 | 6 | M2904 | |
| Coexpression | ZHANG_UTERUS_C4_MYOFIBROBLAST | 1.61e-12 | 369 | 19 | 9 | MM16610 | |
| Coexpression | TABULA_MURIS_SENIS_LUNG_FIBROBLAST_OF_LUNG_AGEING | 1.75e-12 | 224 | 19 | 8 | MM3767 | |
| Coexpression | DARWICHE_SKIN_TUMOR_PROMOTER_DN | 1.81e-12 | 225 | 19 | 8 | MM496 | |
| Coexpression | ZHANG_UTERUS_C13_EPITHELIAL1_CELL | 2.35e-12 | 385 | 19 | 9 | MM16619 | |
| Coexpression | TABULA_MURIS_SENIS_LUNG_ADVENTITIAL_CELL_AGEING | 2.49e-12 | 234 | 19 | 8 | MM3761 | |
| Coexpression | TABULA_MURIS_SENIS_DIAPHRAGM_MESENCHYMAL_STEM_CELL_AGEING | 3.10e-12 | 397 | 19 | 9 | MM3695 | |
| Coexpression | GOLDRATH_ANTIGEN_RESPONSE | 3.10e-12 | 397 | 19 | 9 | MM1255 | |
| Coexpression | TABULA_MURIS_SENIS_BLADDER_ENDOTHELIAL_CELL_AGEING | 4.91e-12 | 418 | 19 | 9 | MM3681 | |
| Coexpression | BERENJENO_TRANSFORMED_BY_RHOA_DN | 5.24e-12 | 421 | 19 | 9 | MM985 | |
| Coexpression | NADLER_OBESITY_UP | 5.86e-12 | 67 | 19 | 6 | MM1007 | |
| Coexpression | FOSTER_TOLERANT_MACROPHAGE_DN | 7.02e-12 | 435 | 19 | 9 | MM1221 | |
| Coexpression | MCBRYAN_PUBERTAL_TGFB1_TARGETS_DN | 7.69e-12 | 70 | 19 | 6 | MM994 | |
| Coexpression | PLASARI_TGFB1_TARGETS_10HR_DN | 8.07e-12 | 271 | 19 | 8 | MM1075 | |
| Coexpression | TABULA_MURIS_SENIS_LIVER_NK_CELL_AGEING | 1.31e-11 | 288 | 19 | 8 | MM3751 | |
| Coexpression | PETROVA_ENDOTHELIUM_LYMPHATIC_VS_BLOOD_DN | 1.43e-11 | 162 | 19 | 7 | M1459 | |
| Coexpression | CSR_LATE_UP.V1_UP | 1.70e-11 | 166 | 19 | 7 | M2660 | |
| Coexpression | MCBRYAN_PUBERTAL_BREAST_6_7WK_DN | 2.94e-11 | 87 | 19 | 6 | MM992 | |
| Coexpression | SWEET_LUNG_CANCER_KRAS_UP | 4.36e-11 | 534 | 19 | 9 | MM1050 | |
| Coexpression | GALINDO_IMMUNE_RESPONSE_TO_ENTEROTOXIN | 4.43e-11 | 93 | 19 | 6 | MM1149 | |
| Coexpression | TABULA_MURIS_SENIS_MAMMARY_GLAND_T_CELL_AGEING | 5.22e-11 | 545 | 19 | 9 | MM3785 | |
| Coexpression | LI_INDUCED_T_TO_NATURAL_KILLER_UP | 5.29e-11 | 343 | 19 | 8 | MM1059 | |
| Coexpression | IVANOVA_HEMATOPOIESIS_LATE_PROGENITOR | 5.48e-11 | 548 | 19 | 9 | MM1013 | |
| Coexpression | TABULA_MURIS_SENIS_MAMMARY_GLAND_MACROPHAGE_AGEING | 5.73e-11 | 97 | 19 | 6 | MM3789 | |
| Coexpression | GSE9988_ANTI_TREM1_VS_LOW_LPS_MONOCYTE_UP | 5.89e-11 | 198 | 19 | 7 | M5846 | |
| Coexpression | GSE41176_UNSTIM_VS_ANTI_IGM_STIM_BCELL_3H_UP | 6.10e-11 | 199 | 19 | 7 | M9915 | |
| Coexpression | GSE360_L_DONOVANI_VS_B_MALAYI_HIGH_DOSE_MAC_UP | 6.10e-11 | 199 | 19 | 7 | M5235 | |
| Coexpression | GSE42088_UNINF_VS_LEISHMANIA_INF_DC_2H_UP | 6.32e-11 | 200 | 19 | 7 | M9900 | |
| Coexpression | GSE360_HIGH_DOSE_B_MALAYI_VS_M_TUBERCULOSIS_DC_DN | 6.32e-11 | 200 | 19 | 7 | M5228 | |
| Coexpression | GSE13484_UNSTIM_VS_YF17D_VACCINE_STIM_PBMC_DN | 6.32e-11 | 200 | 19 | 7 | M3279 | |
| Coexpression | GSE360_L_MAJOR_VS_B_MALAYI_HIGH_DOSE_MAC_UP | 6.32e-11 | 200 | 19 | 7 | M5247 | |
| Coexpression | NEMETH_INFLAMMATORY_RESPONSE_LPS_UP | 6.49e-11 | 99 | 19 | 6 | MM1152 | |
| Coexpression | CHEN_LVAD_SUPPORT_OF_FAILING_HEART_UP | 7.79e-11 | 102 | 19 | 6 | M12300 | |
| Coexpression | GHANDHI_DIRECT_IRRADIATION_UP | 9.30e-11 | 105 | 19 | 6 | M2591 | |
| Coexpression | DURCHDEWALD_SKIN_CARCINOGENESIS_UP | 1.31e-10 | 111 | 19 | 6 | MM705 | |
| Coexpression | GRAESSMANN_RESPONSE_TO_MC_AND_SERUM_DEPRIVATION_DN | 1.38e-10 | 112 | 19 | 6 | MM1095 | |
| Coexpression | NAKAJIMA_MAST_CELL | 1.52e-10 | 46 | 19 | 5 | M389 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C3_PRIMITIVE_ERYTHROCYTE | 1.54e-10 | 114 | 19 | 6 | M45759 | |
| Coexpression | WANG_TUMOR_INVASIVENESS_UP | 1.86e-10 | 402 | 19 | 8 | MM1248 | |
| Coexpression | KAN_RESPONSE_TO_ARSENIC_TRIOXIDE | 2.44e-10 | 123 | 19 | 6 | M1784 | |
| Coexpression | MARTINEZ_RB1_AND_TP53_TARGETS_DN | 2.48e-10 | 650 | 19 | 9 | MM1042 | |
| Coexpression | TABULA_MURIS_SENIS_KIDNEY_KIDNEY_DISTAL_CONVOLUTED_TUBULE_EPITHELIAL_CELL_AGEING | 2.56e-10 | 124 | 19 | 6 | MM3726 | |
| Coexpression | MARTINEZ_TP53_TARGETS_DN | 2.81e-10 | 659 | 19 | 9 | MM1040 | |
| Coexpression | HEVNER_CORTEX_RADIAL_GLIA_PROGENITORS | 3.29e-10 | 432 | 19 | 8 | MM419 | |
| Coexpression | PECE_MAMMARY_STEM_CELL_UP | 5.11e-10 | 139 | 19 | 6 | M2534 | |
| Coexpression | QI_HYPOXIA | 5.34e-10 | 140 | 19 | 6 | MM1290 | |
| CoexpressionAtlas | Pluripotent Stem Cells-reprogram_NA_vs_Pluripotent Stem Cells-reprogram_OS-NL-Confounder_removed-fold2.0_adjp0.05 | 2.88e-16 | 78 | 16 | 8 | PCBC_ratio_ESC_vs_iPSC_method-OS-NL_cfr-2X-p05 | |
| CoexpressionAtlas | SC blastocyst_vs_SC fibroblast-Confounder_removed-fold2.0_adjp0.05 | 1.53e-14 | 9 | 16 | 5 | PCBC_ratio_SC blastocyst_vs_SC fibroblast_cfr-2X-p05 | |
| CoexpressionAtlas | AravindRamakr_StemCell-hypoxiaGrown_fromBlastocyst-derived-humanEmbryonicStemCells_top-relative-expression-ranked_1000_k-means-cluster#2 | 6.44e-12 | 266 | 16 | 8 | Arv_SC-hpx_blastocyst_1000_K2 | |
| CoexpressionAtlas | SC-LF blastocyst_vs_SC blastocyst-Confounder_removed-fold2.0_adjp0.05 | 1.45e-10 | 393 | 16 | 8 | PCBC_ratio_SC-LF blastocyst_vs_SC blastocyst_cfr-2X-p05 | |
| CoexpressionAtlas | Endoderm Differentiated Cells-reprogram_NA_vs_Endoderm Differentiated Cells-reprogram_OSKM-L-Confounder_removed-fold2.0_adjp0.05 | 1.46e-10 | 45 | 16 | 5 | PCBC_ratio_DE_from-ESC_vs_DE_from-OSKM-L_cfr-2X-p05 | |
| CoexpressionAtlas | Endoderm Differentiated Cells-method_NA_vs_Endoderm Differentiated Cells-method_mRNA-Confounder_removed-fold2.0_adjp0.05 | 1.46e-10 | 45 | 16 | 5 | PCBC_ratio_DE_from-ESC_vs_DE_from-mRNA_cfr-2X-p05 | |
| CoexpressionAtlas | AravindRamakr_StemCell-H9hpx_top-relative-expression-ranked_1000 | 2.79e-10 | 987 | 16 | 10 | Arv_SC-H9hpx_1000 | |
| CoexpressionAtlas | AravindRamakr_StemCell-hypoxiaGrown_fromBlastocyst-derived-humanEmbryonicStemCells_top-relative-expression-ranked_1000 | 2.79e-10 | 987 | 16 | 10 | Arv_SC-hpx_blastocyst_1000 | |
| CoexpressionAtlas | AravindRamakr_StemCell-hypoxiaGrown_fromBlastocyst-derived-humanEmbryonicStemCells_top-relative-expression-ranked_500_k-means-cluster#2 | 1.40e-09 | 163 | 16 | 6 | Arv_SC-hpx_blastocyst_500_K2 | |
| CoexpressionAtlas | AravindRamakr_StemCell-H9hpx_top-relative-expression-ranked_500_k-means-cluster#3 | 2.15e-09 | 175 | 16 | 6 | Arv_SC-H9hpx_500_K3 | |
| CoexpressionAtlas | ECTO amniotic fluid MSC_vs_ECTO blastocyst-Confounder_removed-fold2.0_adjp0.05 | 2.81e-09 | 183 | 16 | 6 | PCBC_ratio_ECTO amniotic fluid MSC_vs_ECTO blastocyst_cfr-2X-p05 | |
| CoexpressionAtlas | Pluripotent Stem Cells_vs_Endoderm Differentiated Cells-Confounder_removed-fold2.0_adjp0.05 | 8.75e-09 | 406 | 16 | 7 | PCBC_ratio_SC_vs_DE_cfr-2X-p05 | |
| CoexpressionAtlas | Pluripotent Stem Cells-method_NA_vs_Pluripotent Stem Cells-method_lenti Cre-excised-Confounder_removed-fold2.0_adjp0.05 | 1.23e-08 | 7 | 16 | 3 | PCBC_ratio_ESC_vs_iPSC_method-lenti Cre-excised_cfr-2X-p05 | |
| CoexpressionAtlas | Pluripotent Stem Cells-reprogram_NA_vs_Pluripotent Stem Cells-reprogram_OSKM-Confounder_removed-fold2.0_adjp0.05 | 1.96e-08 | 8 | 16 | 3 | PCBC_ratio_ESC_vs_iPSC_method-OSKM_cfr-2X-p05 | |
| CoexpressionAtlas | AravindRamakr_StemCell-H9hpx_top-relative-expression-ranked_1000_k-means-cluster#4 | 7.58e-07 | 244 | 16 | 5 | Arv_SC-H9hpx_1000_K4 | |
| CoexpressionAtlas | Pluripotent Stem Cells_vs_Mesoderm Day 5-Confounder_removed-fold2.0_adjp0.05 | 8.62e-07 | 796 | 16 | 7 | PCBC_ratio_SC_vs_MESO-5_cfr-2X-p05 | |
| CoexpressionAtlas | SC blastocyst_vs_SC amniotic fluid MSC-Confounder_removed-fold2.0_adjp0.05 | 9.03e-07 | 26 | 16 | 3 | PCBC_ratio_SC blastocyst_vs_SC amniotic fluid MSC_cfr-2X-p05 | |
| CoexpressionAtlas | AravindRamakr_StemCell-H9hpx_top-relative-expression-ranked_500 | 9.87e-07 | 492 | 16 | 6 | Arv_SC-H9hpx_500 | |
| CoexpressionAtlas | AravindRamakr_StemCell-hypoxiaGrown_fromBlastocyst-derived-humanEmbryonicStemCells_top-relative-expression-ranked_500 | 9.87e-07 | 492 | 16 | 6 | Arv_SC-hpx_blastocyst_500 | |
| CoexpressionAtlas | AravindRamakr_StemCell-H9hpx_top-relative-expression-ranked_1000_k-means-cluster#3 | 1.68e-06 | 120 | 16 | 4 | Arv_SC-H9hpx_1000_K3 | |
| CoexpressionAtlas | SC blastocyst_vs_SC bone marrow-Confounder_removed-fold2.0_adjp0.05 | 1.89e-06 | 33 | 16 | 3 | PCBC_ratio_SC blastocyst_vs_SC bone marrow_cfr-2X-p05 | |
| CoexpressionAtlas | DE blastocyst_vs_DE UCB CD34+Z-Confounder_removed-fold2.0_adjp0.05 | 2.34e-06 | 307 | 16 | 5 | PCBC_ratio_DE blastocyst_vs_DE UCB CD34+Z_cfr-2X-p05 | |
| CoexpressionAtlas | ratio_StemCell_vs_induced-Mesoderm_top-relative-expression-ranked_1000 | 3.78e-06 | 993 | 16 | 7 | PCBC_ratio_SC_vs_MESO-5_1000 | |
| CoexpressionAtlas | Pluripotent Stem Cells_vs_Embryoid Body Cells-Confounder_removed-fold2.0_adjp0.05 | 1.04e-05 | 1157 | 16 | 7 | PCBC_ratio_SC_vs_EB_cfr-2X-p05 | |
| CoexpressionAtlas | AravindRamakr_StemCell-H9hpx_top-relative-expression-ranked_2500_k-means-cluster#2 | 1.18e-05 | 428 | 16 | 5 | Arv_SC-H9hpx_2500_K2 | |
| CoexpressionAtlas | Pluripotent Stem Cells-method_NA_vs_Pluripotent Stem Cells-method_plasmid-Confounder_removed-fold2.0_adjp0.05 | 1.49e-05 | 8 | 16 | 2 | PCBC_ratio_ESC_vs_iPSC_method-plasmid_cfr-2X-p05 | |
| CoexpressionAtlas | Ectoderm Differentiated Cells-method_NA_vs_Ectoderm Differentiated Cells-method_mRNA-Confounder_removed-fold2.0_adjp0.05 | 2.11e-05 | 73 | 16 | 3 | PCBC_ratio_ECTO_from-ESC_vs_ECTO_from-mRNA_cfr-2X-p05 | |
| CoexpressionAtlas | Ectoderm Differentiated Cells-reprogram_NA_vs_Ectoderm Differentiated Cells-reprogram_OSKM-L-Confounder_removed-fold2.0_adjp0.05 | 2.11e-05 | 73 | 16 | 3 | PCBC_ratio_ECTO_from-ESC_vs_ECTO_from-OSKM-L_cfr-2X-p05 | |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_reference_BronchSmoothMuscl_top-relative-expression-ranked_1000 | 5.14e-05 | 981 | 16 | 6 | PCBC_ctl_BronchSmoothMuscl_1000 | |
| CoexpressionAtlas | ratio_StemCell_vs_EmbryoidBody_top-relative-expression-ranked_1000 | 5.23e-05 | 984 | 16 | 6 | PCBC_ratio_SC_vs_EB_1000 | |
| CoexpressionAtlas | ECTO bone marrow_vs_ECTO blastocyst-Confounder_removed-fold2.0_adjp0.05 | 7.61e-05 | 112 | 16 | 3 | PCBC_ratio_ECTO bone marrow_vs_ECTO blastocyst_cfr-2X-p05 | |
| CoexpressionAtlas | AravindRamakr_StemCell-hypoxiaGrown_fromBlastocyst-derived-humanEmbryonicStemCells_top-relative-expression-ranked_2500_k-means-cluster#4 | 2.40e-04 | 426 | 16 | 4 | Arv_SC-hpx_blastocyst_2500_K4 | |
| CoexpressionAtlas | EB cord blood_vs_EB blastocyst-Confounder_removed-fold2.0_adjp0.05 | 3.14e-04 | 181 | 16 | 3 | PCBC_ratio_EB cord blood_vs_EB blastocyst_cfr-2X-p05 | |
| CoexpressionAtlas | AravindRamakr_StemCell-HD_top-relative-expression-ranked_1000_k-means-cluster#3 | 3.25e-04 | 183 | 16 | 3 | Arv_SC-HD_1000_K3 | |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_reference_BronchSmoothMuscl_top-relative-expression-ranked_500 | 4.06e-04 | 489 | 16 | 4 | PCBC_ctl_BronchSmoothMuscl_500 | |
| CoexpressionAtlas | ratio_StemCell_vs_induced-DefinitiveEndoderm_top-relative-expression-ranked_1000 | 5.38e-04 | 960 | 16 | 5 | PCBC_ratio_SC_vs_DE_1000 | |
| CoexpressionAtlas | JC_hmvEC_top-relative-expression-ranked_500_k-means-cluster#1 | 5.49e-04 | 219 | 16 | 3 | JC_hmvEC_500_K1 | |
| CoexpressionAtlas | ratio_StemCell_vs_induced-Mesoderm_top-relative-expression-ranked_1000_k-means-cluster#5 | 5.90e-04 | 540 | 16 | 4 | ratio_SC_vs_MESO_1000_K5 | |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_reference_SmallAirwayEpithel_top-relative-expression-ranked_1000 | 6.11e-04 | 987 | 16 | 5 | PCBC_ctl_SmallAirwayEpithel_1000 | |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_reference_BronchioEpithel_top-relative-expression-ranked_1000 | 6.19e-04 | 990 | 16 | 5 | PCBC_ctl_BronchioEpithel_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Facial Mesenchyne_top-relative-expression-ranked_500_k-means-cluster#5 | 6.91e-04 | 52 | 16 | 2 | Facebase_RNAseq_e9.5_Facial Mesenchyne_500_K5 | |
| CoexpressionAtlas | thyroid gland | 7.16e-04 | 240 | 16 | 3 | thyroid gland | |
| CoexpressionAtlas | ratio_StemCell_vs_induced-DefinitiveEndoderm_top-relative-expression-ranked_500_k-means-cluster#5 | 9.23e-04 | 262 | 16 | 3 | ratio_SC_vs_DE_500_K5 | |
| CoexpressionAtlas | ratio_StemCell_vs_EmbryoidBody_top-relative-expression-ranked_1000_k-means-cluster#2 | 9.49e-04 | 613 | 16 | 4 | ratio_SC_vs_EB_1000_K2 | |
| CoexpressionAtlas | facebase_RNAseq_e9.5_MaxArch_2500_K1 | 1.28e-03 | 71 | 16 | 2 | facebase_RNAseq_e9.5_MaxArch_2500_K1 | |
| CoexpressionAtlas | AravindRamakr_StemCell-H9hpx_top-relative-expression-ranked_1000_k-means-cluster#1 | 1.39e-03 | 74 | 16 | 2 | Arv_SC-H9hpx_1000_K1 | |
| CoexpressionAtlas | Myeloid Cells, DC.103-11b+24+.Lu, MHCII+ CD11c+ CD103- CD11b+ CD24+, Lung, avg-2 | 1.43e-03 | 75 | 16 | 2 | GSM854269_100 | |
| CoexpressionAtlas | Myeloid Cells, DC.103+11b-.PolyIC.Lu, CD45 MHCII CD11c CD103 CD11b, Lung, avg-3 | 1.55e-03 | 78 | 16 | 2 | GSM605820_100 | |
| CoexpressionAtlas | JC_iEC_top-relative-expression-ranked_2500_k-means-cluster#2 | 1.58e-03 | 316 | 16 | 3 | JC_iEC_2500_K2 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_MandArch_2500_K4 | 1.67e-03 | 81 | 16 | 2 | facebase_RNAseq_e10.5_MandArch_2500_K4 | |
| CoexpressionAtlas | Myeloid Cells, DC.103-11b+.PolyIC.Lu, CD45 MHCII CD11c CD103 CD11b, Lung, avg-3 | 1.67e-03 | 81 | 16 | 2 | GSM605823_100 | |
| CoexpressionAtlas | kidney | 1.69e-03 | 323 | 16 | 3 | kidney | |
| CoexpressionAtlas | MESO-5 cord blood_vs_MESO-5 blastocyst-Confounder_removed-fold2.0_adjp0.05 | 1.83e-03 | 85 | 16 | 2 | PCBC_ratio_MESO-5 cord blood_vs_MESO-5 blastocyst_cfr-2X-p05 | |
| CoexpressionAtlas | AravindRamakr_StemCell-hypoxiaGrown_fromBlastocyst-derived-humanEmbryonicStemCells_top-relative-expression-ranked_1000_k-means-cluster#5 | 2.01e-03 | 89 | 16 | 2 | Arv_SC-hpx_blastocyst_1000_K5 | |
| CoexpressionAtlas | Stem Cells, SC.MEP.BM, Lineage- Kit+ Sca1- CD34- FcgR-/low, Bone marrow, avg-2 | 2.01e-03 | 89 | 16 | 2 | GSM791108_100 | |
| CoexpressionAtlas | Myeloid Cells, DC.LC.Sk, MHCII+ CD11b+ CD45+, Skin, avg-2 | 2.10e-03 | 91 | 16 | 2 | GSM538280_100 | |
| CoexpressionAtlas | ratio_StemCell_vs_induced-DefinitiveEndoderm_top-relative-expression-ranked_1000_k-means-cluster#4 | 2.10e-03 | 349 | 16 | 3 | ratio_SC_vs_DE_1000_K4 | |
| CoexpressionAtlas | ratio_StemCell_vs_induced-Mesoderm_top-relative-expression-ranked_2500_k-means-cluster#3 | 2.18e-03 | 768 | 16 | 4 | ratio_SC_vs_MESO_2500_K3 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Proximal Tubules_emap-28005_k-means-cluster#4_top-relative-expression-ranked_500 | 2.28e-03 | 95 | 16 | 2 | gudmap_developingKidney_e15.5_Proximal Tubules_500_k4 | |
| CoexpressionAtlas | Stromal Cells, Fi.Sk, gp38+ CD140a+, Skin, avg-4 | 2.38e-03 | 97 | 16 | 2 | GSM777046_100 | |
| CoexpressionAtlas | ratio_StemCell_vs_induced-Ectoderm_top-relative-expression-ranked_100 | 2.47e-03 | 99 | 16 | 2 | PCBC_ratio_SC_vs_ECTO_100 | |
| CoexpressionAtlas | ratio_StemCell_vs_EmbryoidBody_top-relative-expression-ranked_100 | 2.47e-03 | 99 | 16 | 2 | PCBC_ratio_SC_vs_EB_100 | |
| CoexpressionAtlas | JC_hmvEC_top-relative-expression-ranked_100 | 2.47e-03 | 99 | 16 | 2 | JC_hmvEC_100 | |
| CoexpressionAtlas | ratio_StemCell_vs_induced-DefinitiveEndoderm_top-relative-expression-ranked_100 | 2.47e-03 | 99 | 16 | 2 | PCBC_ratio_SC_vs_DE_100 | |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_reference_BronchSmoothMuscl_top-relative-expression-ranked_100 | 2.47e-03 | 99 | 16 | 2 | PCBC_ctl_BronchSmoothMuscl_100 | |
| CoexpressionAtlas | ratio_StemCell_vs_induced-Mesoderm_top-relative-expression-ranked_100 | 2.47e-03 | 99 | 16 | 2 | PCBC_ratio_SC_vs_MESO-5_100 | |
| CoexpressionAtlas | AravindRamakr_StemCell-H9hpx_top-relative-expression-ranked_100 | 2.47e-03 | 99 | 16 | 2 | Arv_SC-H9hpx_100 | |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_reference_CardioEndothel_top-relative-expression-ranked_100 | 2.47e-03 | 99 | 16 | 2 | PCBC_ctl_CardioEndothel_100 | |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_reference_CardiacMyocyte_top-relative-expression-ranked_100 | 2.47e-03 | 99 | 16 | 2 | PCBC_ctl_CardiacMyocyte_100 | |
| CoexpressionAtlas | AravindRamakr_StemCell-hypoxiaGrown_fromBlastocyst-derived-humanEmbryonicStemCells_top-relative-expression-ranked_100 | 2.47e-03 | 99 | 16 | 2 | Arv_SC-hpx_blastocyst_100 | |
| CoexpressionAtlas | Ectoderm Differentiated Cells-method_NA_vs_Ectoderm Differentiated Cells-method_plasmid-Confounder_removed-fold2.0_adjp0.05 | 2.62e-03 | 102 | 16 | 2 | PCBC_ratio_ECTO_from-ESC_vs_ECTO_from-plasmid_cfr-2X-p05 | |
| CoexpressionAtlas | DevelopingKidney_e14.5 whole kidney - wildtype_emap-6674_k-means-cluster#2_top-relative-expression-ranked_500 | 2.67e-03 | 103 | 16 | 2 | gudmap_developingKidney_e14.5 whole kidney - wildtype_500_k2 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_early proxim tubul_emap-28005_k-means-cluster#5_top-relative-expression-ranked_500 | 2.73e-03 | 104 | 16 | 2 | gudmap_developingKidney_e15.5_early proxim tubul_500_k5 | |
| CoexpressionAtlas | JC_hmvEC_top-relative-expression-ranked_1000_k-means-cluster#1 | 2.88e-03 | 107 | 16 | 2 | JC_hmvEC_1000_K1 | |
| CoexpressionAtlas | facebase_RNAseq_e8.5_ParaxMesoderm_2500_K0 | 3.04e-03 | 110 | 16 | 2 | facebase_RNAseq_e8.5_ParaxMesoderm_2500_K0 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e15.5_ureteral tissue_emap-8234_k-means-cluster#3_top-relative-expression-ranked_200 | 3.26e-03 | 114 | 16 | 2 | gudmap_developingLowerUrinaryTract_e15.5_ureteral tissue_200_k3 | |
| CoexpressionAtlas | Pluripotent Stem Cells_vs_Ectoderm Differentiated Cells-Confounder_removed-fold2.0_adjp0.05 | 3.80e-03 | 895 | 16 | 4 | PCBC_ratio_SC_vs_ECTO_cfr-2X-p05 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Facial Mesenchyne_top-relative-expression-ranked_1000_k-means-cluster#1 | 3.91e-03 | 125 | 16 | 2 | Facebase_RNAseq_e9.5_Facial Mesenchyne_1000_K1 | |
| CoexpressionAtlas | AravindRamakr_StemCell-HD_top-relative-expression-ranked_500_k-means-cluster#2 | 3.97e-03 | 126 | 16 | 2 | Arv_SC-HD_500_K2 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_anlage of loop of Henle_emap-31283_k-means-cluster#5_top-relative-expression-ranked_1000 | 4.41e-03 | 133 | 16 | 2 | gudmap_developingKidney_e15.5_1000_k5 | |
| CoexpressionAtlas | JC_hmvEC_top-relative-expression-ranked_2500_k-means-cluster#1 | 4.46e-03 | 936 | 16 | 4 | JC_hmvEC_2500_K1 | |
| CoexpressionAtlas | AravindRamakr_StemCell-hypoxiaGrown_fromBlastocyst-derived-humanEmbryonicStemCells_top-relative-expression-ranked_2500_k-means-cluster#2 | 4.62e-03 | 945 | 16 | 4 | Arv_SC-hpx_blastocyst_2500_K2 | |
| CoexpressionAtlas | AravindRamakr_StemCell_from_inducedPluripotentialStemCells_derived from_from_fibroblast_top-relative-expression-ranked_500_k-means-cluster#3 | 4.81e-03 | 139 | 16 | 2 | Arv_SC_fibroblast_500_K3 | |
| CoexpressionAtlas | ratio_StemCell_vs_induced-Mesoderm_top-relative-expression-ranked_1000_k-means-cluster#1 | 4.94e-03 | 141 | 16 | 2 | ratio_SC_vs_MESO_1000_K1 | |
| CoexpressionAtlas | Ectoderm Differentiated Cells_vs_Mesoderm Day 5-Confounder_removed-fold2.0_adjp0.05 | 5.01e-03 | 967 | 16 | 4 | PCBC_ratio_ECTO_vs_MESO-5_cfr-2X-p05 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Olfactory Pit_top-relative-expression-ranked_500_k-means-cluster#3 | 5.15e-03 | 144 | 16 | 2 | Facebase_RNAseq_e10.5_Olfactory Pit_500_K3 | |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_reference_CardiacMyocyte_top-relative-expression-ranked_1000 | 5.16e-03 | 975 | 16 | 4 | PCBC_ctl_CardiacMyocyte_1000 | |
| CoexpressionAtlas | JC_iEC_top-relative-expression-ranked_1000_k-means-cluster#4 | 5.22e-03 | 145 | 16 | 2 | JC_iEC_1000_K4 | |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_reference_CardioEndothel_top-relative-expression-ranked_1000 | 5.22e-03 | 978 | 16 | 4 | PCBC_ctl_CardioEndothel_1000 | |
| CoexpressionAtlas | ratio_StemCell_vs_EmbryoidBody_top-relative-expression-ranked_2500_k-means-cluster#5 | 5.22e-03 | 978 | 16 | 4 | ratio_SC_vs_EB_2500_K5 | |
| CoexpressionAtlas | AravindRamakr_StemCell-H9hpx_top-relative-expression-ranked_2500_k-means-cluster#5 | 5.28e-03 | 981 | 16 | 4 | Arv_SC-H9hpx_2500_K5 | |
| CoexpressionAtlas | ratio_StemCell_vs_induced-Ectoderm_top-relative-expression-ranked_1000 | 5.33e-03 | 984 | 16 | 4 | PCBC_ratio_SC_vs_ECTO_1000 | |
| CoexpressionAtlas | JC_hmvEC_top-relative-expression-ranked_1000 | 5.45e-03 | 990 | 16 | 4 | JC_hmvEC_1000 | |
| CoexpressionAtlas | ratio_StemCell_vs_induced-Ectoderm_top-relative-expression-ranked_500 | 5.53e-03 | 492 | 16 | 3 | PCBC_ratio_SC_vs_ECTO_500 | |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_reference_CardiacMyocyte_top-relative-expression-ranked_500 | 5.56e-03 | 493 | 16 | 3 | PCBC_ctl_CardiacMyocyte_500 | |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_reference_SmallAirwayEpithel_top-relative-expression-ranked_500 | 5.56e-03 | 493 | 16 | 3 | PCBC_ctl_SmallAirwayEpithel_500 | |
| CoexpressionAtlas | ratio_StemCell_vs_EmbryoidBody_top-relative-expression-ranked_500 | 5.59e-03 | 494 | 16 | 3 | PCBC_ratio_SC_vs_EB_500 | |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_reference_CardioEndothel_top-relative-expression-ranked_500 | 5.62e-03 | 495 | 16 | 3 | PCBC_ctl_CardioEndothel_500 | |
| CoexpressionAtlas | JC_hmvEC_top-relative-expression-ranked_500 | 5.62e-03 | 495 | 16 | 3 | JC_hmvEC_500 | |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_reference_PulmonMicrovasc_top-relative-expression-ranked_500 | 5.62e-03 | 495 | 16 | 3 | PCBC_ctl_PulmonMicrovasc_500 | |
| ToppCell | wk_08-11-Hematologic-Meg-ery-Primitive_erythrocyte|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 1.82e-17 | 179 | 19 | 9 | 3c8046f43da5a02fa4278a7175b9cd8cf95b8e27 | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Epithelial-Tuft-related|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.01e-17 | 181 | 19 | 9 | 1c04e53f46992a0aea9d3eee985681ec4e71f80d | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Epithelial-Tuft-related-BEST4+_epithelial|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.01e-17 | 181 | 19 | 9 | 83adf61f44cebe9e75de175c5dc39237fbf9ed24 | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Differentiated-like-MES-like-MES-like_hypoxia/MHC-A|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.85e-17 | 188 | 19 | 9 | 1a751452c0f1f34b3c20fad2fb52c378ab2d0207 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Degenerative_Proximal_Tubule_Epithelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.38e-17 | 197 | 19 | 9 | eb119e048d5ea1be5f427bb9fb60e5e7b6e84d92 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Epithelial-Tuft-related-BEST4+_epithelial|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.45e-15 | 169 | 19 | 8 | 1dfaf9a6b433a5ee86a11962af188978c2543278 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Epithelial-Tuft-related|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.45e-15 | 169 | 19 | 8 | 3e267ec9f884df326315500dfd751b04a3dd91bd | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Hematopoietic-Red_blood_cells-RBC|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.69e-15 | 171 | 19 | 8 | f21eae4dd2e0a566eff792d19367e96ffb0b74ba | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Hematopoietic-Red_blood_cells|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.69e-15 | 171 | 19 | 8 | d428c2859a1efc284610ca241a6dae9f182309cd | |
| ToppCell | wk_08-11-Hematologic-Meg-ery|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 4.67e-15 | 183 | 19 | 8 | 7eecb8d80e31ca26c2e6ce43bf0f2c71be1643e4 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Epithelial-goblet|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.88e-15 | 184 | 19 | 8 | 936b39377eebea3961d702532779f6cd27953be7 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Epithelial-goblet-Goblet_cell|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.88e-15 | 184 | 19 | 8 | 886d2d9bf2fe31207f17e3edc309ef44029924e1 | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Differentiated-like-MES-like-MES-like_hypoxia_independent-A|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.33e-15 | 190 | 19 | 8 | ad0d9aed8c9c99551765d14730d70ebef1ea856b | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Differentiated-like-MES-like-MES-like_hypoxia_independent-D|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.33e-15 | 190 | 19 | 8 | 799351fea7490d4159271d020c43c845ef37c788 | |
| ToppCell | NS-critical-d_0-4|critical / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 6.61e-15 | 191 | 19 | 8 | 769942a6a31c13c583dc38e8a762df2f5c06c2fb | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Epithelial-mature_enterocytic-Colonocyte|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.89e-15 | 192 | 19 | 8 | 1a3d95a9801cc4569b67fa652b2af46c4dedbaef | |
| ToppCell | Macrophages-Donor_07|World / lung cells shred on cell class, cell subclass, sample id | 7.50e-15 | 194 | 19 | 8 | cbb1c65ccee58b2892f7d3fa45773099411c6104 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Epithelial-goblet|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.82e-15 | 195 | 19 | 8 | 09605533aa5947bb2e5a6725c1ce89f79d330bf5 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Epithelial-goblet-Goblet_cell|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.82e-15 | 195 | 19 | 8 | 7ff04c45a02df01e3816f3c1d43585a93182a730 | |
| ToppCell | Healthy_Control-Myeloid-Macrophages-FCN1+SPP1+|Healthy_Control / Condition, Lineage, Cell class and cell subclass | 8.85e-15 | 198 | 19 | 8 | aa90326b82e21de37af5642df6a70a8b21af7f04 | |
| ToppCell | ILEUM-inflamed-(3)_MNP-(3)_Inf._Macrophages|(3)_MNP / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 8.85e-15 | 198 | 19 | 8 | ebc064dede536eda7715af0675fd4e657ff4ac5d | |
| ToppCell | COVID-19-kidney-PCT-S3-1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 8.85e-15 | 198 | 19 | 8 | 36a60397f49f5381ae377155b73e1891448846b7 | |
| ToppCell | medial|World / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 8.85e-15 | 198 | 19 | 8 | 071658de0c43f302172692aa0b4b507dbad7be50 | |
| ToppCell | COVID-19-kidney-PCT-S3-1|kidney / Disease (COVID-19 only), tissue and cell type | 9.22e-15 | 199 | 19 | 8 | 3e6cfc3c0b2edce0d51db9de80e38f724e6c0cb8 | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Differentiated-like-MES-like|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 9.22e-15 | 199 | 19 | 8 | e09bd3153dd60d06584707b259c78375b47415c8 | |
| ToppCell | 3'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophage_CCL3+-Alveolar_macrophage_CCL3+_L.1.0.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.22e-15 | 199 | 19 | 8 | 8fcb32eee0ec0dd88209e723a6f82f425c73ca40 | |
| ToppCell | background|World / Sample and Cell Type and Tumor Cluster (all cells) | 9.22e-15 | 199 | 19 | 8 | 5a6d0e00bfe1351eea192b54020bedeef78854e9 | |
| ToppCell | 5'-Adult-SmallIntestine-Epithelial-epithelial_progenitor_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.60e-15 | 200 | 19 | 8 | fc77a0c53201c60933d188ea8d4d86bac6325422 | |
| ToppCell | background-Hepatocytes|World / Sample and Cell Type and Tumor Cluster (all cells) | 9.60e-15 | 200 | 19 | 8 | 423cca10df6ae0489a8fe7e7df87e70364dac022 | |
| ToppCell | 5'-Adult-SmallIntestine-Epithelial-epithelial_progenitor_cell-TA|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.60e-15 | 200 | 19 | 8 | 742441800a2d167c19cee4816ff77424ae6675c6 | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Epithelial-epithelial_progenitor_cell|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.91e-13 | 171 | 19 | 7 | f2b31c97bbcc5164fc279ed0362007878887ad5e | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Epithelial-epithelial_progenitor_cell-TA|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.33e-13 | 173 | 19 | 7 | 021457c7bdb55de7351e43322d360e8fd7061658 | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Differentiated-like|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.55e-13 | 174 | 19 | 7 | b31a6c9d8f7c8cb229c0539d959c19251e2fcd13 | |
| ToppCell | wk_15-18-Hematologic-Meg-ery-Primitive_erythrocyte|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 6.02e-13 | 176 | 19 | 7 | 664a7d15563428d0ae156d97aa88415fd0a0506a | |
| ToppCell | TCGA-Liver-Solid_Tissue_Normal-Liver-Liver_normal_tissue|TCGA-Liver / Sample_Type by Project: Shred V9 | 6.79e-13 | 179 | 19 | 7 | 17ba1eedb6ebf039d3b11d099351d0ac6363c8d1 | |
| ToppCell | TCGA-Liver-Solid_Tissue_Normal|TCGA-Liver / Sample_Type by Project: Shred V9 | 6.79e-13 | 179 | 19 | 7 | 7046f0a426e45fe1b41a25721ee1e33f6fc7f9e3 | |
| ToppCell | TCGA-Liver-Solid_Tissue_Normal-Liver|TCGA-Liver / Sample_Type by Project: Shred V9 | 6.79e-13 | 179 | 19 | 7 | 0e22e840f43ca81a7543dcf33ec17a741cdf7f37 | |
| ToppCell | TCGA-Liver-Solid_Tissue_Normal-Liver-Liver_normal_tissue-2|TCGA-Liver / Sample_Type by Project: Shred V9 | 6.79e-13 | 179 | 19 | 7 | a20bb3ace5be10c5aef330e9268c0ba55f8fee23 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Epithelial-Tuft-related-BEST4+_epithelial|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.06e-13 | 180 | 19 | 7 | 7c7c4d64ff99d0710a7d19d8bc29fc9217394db1 | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Epithelial-epithelial_progenitor_cell-Proximal_progenitor|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.06e-13 | 180 | 19 | 7 | 8d9be9cfdf98e5888654a28ab12e5e89f201af00 | |
| ToppCell | 3'-Child09-12-SmallIntestine-Epithelial-Tuft-related-BEST4+_epithelial|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.06e-13 | 180 | 19 | 7 | b234668bf181522807470e396792e1b54890b719 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Epithelial-Tuft-related|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.06e-13 | 180 | 19 | 7 | 8ba9bba0c9fecf184a4332ba4585fb2439f68cd3 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Epithelial-epithelial_progenitor_cell-TA|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.06e-13 | 180 | 19 | 7 | 271ee52ed8f21f78ddf68e52fc88fe582701675e | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Epithelial-mature_enterocytic-Colonocyte|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.34e-13 | 181 | 19 | 7 | bec917f6f56ae252639a5a76024be5df5c70a6d5 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophage_CCL3+-Alveolar_macrophage_CCL3+_L.1.0.2.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.34e-13 | 181 | 19 | 7 | a8d4b2340d99734bf9379b467fb481c598b9b4fb | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Epithelial-Tuft-related-BEST4+_epithelial|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.63e-13 | 182 | 19 | 7 | e98ca9df33a1a81fc83ecf73d5141a14f2bc985c | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Degenerative_Proximal_Tubule_Epithelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.25e-13 | 184 | 19 | 7 | 2b83c7a808e97abf836f53aa3243543c8f6762fb | |
| ToppCell | 3'-Child04-06-SmallIntestine-Epithelial-Tuft-related-BEST4+_epithelial|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.57e-13 | 185 | 19 | 7 | c3d1a312569f3d619f7295812741cbf068ec6c1f | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Non-neuronal-Macroglial-Astro-Astrocyte-Astro_L1_FGFR3_MT1G|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.90e-13 | 186 | 19 | 7 | 41e03be964044dae690d566bd078dab3d8045eba | |
| ToppCell | primary_auditory_cortex_(A1C)-Non-neuronal-Macroglial-Astro-Astrocyte-Astro_L1_FGFR3_MT1G|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.25e-13 | 187 | 19 | 7 | 401be371b32066db926de3415bb4ce9465749dc3 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Macroglial-Astro-Astrocyte-Astro_L1_FGFR3_MT1G|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.25e-13 | 187 | 19 | 7 | 2b1b2c3792d6c9ab69675ce88842bb589414b530 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Epithelial-mature_enterocytic-Colonocyte|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.60e-13 | 188 | 19 | 7 | d00f48afed62fc60d3530bb3b80ac0162b0b0ed8 | |
| ToppCell | PCW_05-06-Hematologic_ErythroMegGranulo-Hem_ErythroMeg|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 9.60e-13 | 188 | 19 | 7 | 5d6faf45a9c0794b0c30b0a0601c10afbb8aa9ed | |
| ToppCell | PCW_05-06-Hematologic_ErythroMegGranulo|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 9.60e-13 | 188 | 19 | 7 | a0873783f0a2cd852563c05a275dddc72905ced2 | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Epithelial-mature_enterocytic-Colonocyte|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.60e-13 | 188 | 19 | 7 | e7f58cd67afac441204c29676de2ffa7aaafd988 | |
| ToppCell | PCW_05-06-Hematologic_ErythroMegGranulo-Hem_ErythroMeg-erythro|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 9.60e-13 | 188 | 19 | 7 | 29d804232d974a8c0029300345b287005b09bade | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Differentiated-like-MES-like-MES-like_hypoxia/MHC-D|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.03e-12 | 190 | 19 | 7 | ab56800abd1d5cbe2351834a1df749ac7db30892 | |
| ToppCell | 5'-GW_trimst-1-SmallIntestine-Hematopoietic|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.07e-12 | 191 | 19 | 7 | 84c3ccc819fb5acec68daab2e6cc65d5d8909cc4 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Epithelial-Tuft-related|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.07e-12 | 191 | 19 | 7 | 7717cf1d99b4451d7145d91367637895f9a2c1c3 | |
| ToppCell | 5'-GW_trimst-1-SmallIntestine-Hematopoietic-Red_blood_cells|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.07e-12 | 191 | 19 | 7 | 674e7a27b5f736f14f8513e5ef0d56e4e746d989 | |
| ToppCell | 5'-GW_trimst-1-SmallIntestine-Hematopoietic-Red_blood_cells-RBC|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.07e-12 | 191 | 19 | 7 | dd73173a898e29624acb22dd783339f3e696a213 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Epithelial-Tuft-related-BEST4+_epithelial|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.07e-12 | 191 | 19 | 7 | 7065728128e37572b87e6b024374796bd2172e92 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_3|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.11e-12 | 192 | 19 | 7 | 3e1a4cb0d83efd502c8613d41a1692bdda5860ed | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Differentiated-like-MES-like-MES-like_hypoxia_independent|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.16e-12 | 193 | 19 | 7 | a313541cedfcff8fb311b9bc60157359aa103830 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Epithelial|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.20e-12 | 194 | 19 | 7 | 07d8e38cbc2c7f0564c14f7c365f345f901b73b2 | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Epithelial-goblet|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.24e-12 | 195 | 19 | 7 | e1fb987f13482d1fce0428413244be3621136424 | |
| ToppCell | 5'-Adult-SmallIntestine-Epithelial-Tuft-related-BEST4+_epithelial|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.24e-12 | 195 | 19 | 7 | e87b11e3242fdbed2e7f383e6876ec375af32bd4 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.24e-12 | 195 | 19 | 7 | 1a4a5623fa0318ef388cc228c7060e0586a7acf9 | |
| ToppCell | 5'-Adult-SmallIntestine-Epithelial-Tuft-related|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.24e-12 | 195 | 19 | 7 | 23ab7e2a419377c05bab0e92a2457afbcd3d9e07 | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Epithelial-goblet-Goblet_cell|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.24e-12 | 195 | 19 | 7 | 482a2e7db72f0da285bb658943dd668777519734 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Epithelial-mature_enterocytic-Colonocyte|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.24e-12 | 195 | 19 | 7 | 9c24ebce2e3e00b8b692c62a22a53b7d59f0eabb | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Epithelial|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.29e-12 | 196 | 19 | 7 | 0df0dbe60e6f643912e5ff30c22415a0513f9bf1 | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Epithelial-mature_enterocytic|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.29e-12 | 196 | 19 | 7 | 153326be031a58b720da4dab57edd8936d513f8e | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Degenerative_Proximal_Tubule_Epithelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.29e-12 | 196 | 19 | 7 | 3cf73ed99f3efa76b632c16a8b98b6b7758ff63f | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Epithelial-mature_enterocytic-Colonocyte|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.29e-12 | 196 | 19 | 7 | b7748618aaf3ace40940be1b6ca2148e941541a2 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Degenerative_Proximal_Tubule_Epithelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.29e-12 | 196 | 19 | 7 | 52a55bc30e48055823e4161f328ff5808a0ac55c | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Differentiated-like-MES-like-MES-like_hypoxia_independent|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.29e-12 | 196 | 19 | 7 | 19993604ee64ba85e3f53a784fcf1c934e862f61 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Epithelial|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.29e-12 | 196 | 19 | 7 | 79bc7ab96b52b2a542348a13ddd0a4f095698c5e | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Epithelial-mature_enterocytic|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.34e-12 | 197 | 19 | 7 | a6a27e5809ee2c9b56c7e06c35e4f140f9fa13ad | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Degenerative_Proximal_Tubule_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.34e-12 | 197 | 19 | 7 | 291458becbf90e9dda22ea069df7f9a45d827bcd | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.38e-12 | 198 | 19 | 7 | 7db113a6e7962ff26c1e1a43baa1a4230cf5f393 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Epithelial-goblet|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.38e-12 | 198 | 19 | 7 | 9c5d7852f03468394e726c444cac92a043fc6d0e | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Degenerative_Proximal_Tubule_Epithelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.38e-12 | 198 | 19 | 7 | 64d73804902a043bdf66b413b769e853d111c033 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.38e-12 | 198 | 19 | 7 | be305d89d48c67ce922fa71aaf15e24d00c89ff6 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.38e-12 | 198 | 19 | 7 | 8777117249077d4964dd7566aebde7c443475c7e | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Epithelial-goblet-Goblet_cell|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.38e-12 | 198 | 19 | 7 | f95f38cc747fb3549a791288bf8d0518c049ac96 | |
| ToppCell | 5'-Adult-SmallIntestine|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.43e-12 | 199 | 19 | 7 | a5fffe381be1ba7d192b68d1d3937ce47663658e | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Epithelial-goblet-Goblet_cell|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.43e-12 | 199 | 19 | 7 | fb9550bbb1fa206c3132e0a21a646eedb41c281a | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Epithelial-goblet|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.43e-12 | 199 | 19 | 7 | 440f47e320c75f49ef47139b46962de68cee8320 | |
| ToppCell | 3'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophage_MT-positive|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.43e-12 | 199 | 19 | 7 | fd1a9f9ab5eeb8c50005304715bb0f35b7926935 | |
| ToppCell | 3'-Child04-06-SmallIntestine-Epithelial|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.43e-12 | 199 | 19 | 7 | ab71b312635a2b2c98d71b60a299f44bc80a3587 | |
| ToppCell | 3'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophage_MT-positive-Alveolar_macrophage_MT-positive_L.1.0.1.3|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.43e-12 | 199 | 19 | 7 | 8efa724d47b95194d42907ffae17284c3953605e | |
| ToppCell | Macroglial-Astrocytes-GFAP---|Macroglial / cells hierarchy compared to all cells using T-Statistic | 1.49e-12 | 200 | 19 | 7 | 88d66550781a3c9102ff7455f5cff6fb072943cd | |
| ToppCell | Macroglial-Astrocytes-GFAP-|Macroglial / cells hierarchy compared to all cells using T-Statistic | 1.49e-12 | 200 | 19 | 7 | d6a059b0ef763c281c60b1ac76da6079ea822f80 | |
| ToppCell | Macroglial-Astrocytes-GFAP--|Macroglial / cells hierarchy compared to all cells using T-Statistic | 1.49e-12 | 200 | 19 | 7 | 16269fa4adb28fc6ed032bbdba8781237dd0d249 | |
| ToppCell | Macroglial-Astrocytes-GFAP|Macroglial / cells hierarchy compared to all cells using T-Statistic | 1.49e-12 | 200 | 19 | 7 | 79634b1086934412ae92f259ab43554ce545008f | |
| ToppCell | Macroglial-Astrocytes-GFAP----L1-2|Macroglial / cells hierarchy compared to all cells using T-Statistic | 1.49e-12 | 200 | 19 | 7 | c6f43bbbd5df5f2c19ae385f1a6b6a330abede2f | |
| ToppCell | Parenchymal-10x5prime-Immune_Myeloid-Macrophage_alveolar-Macro_alv_MT|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.49e-12 | 200 | 19 | 7 | 63a5ae71cfc2aa878a0cea58bdf99da7534b3551 | |
| ToppCell | wk_08-11-Hematologic-Meg-ery-HMOX1+_primitive_erythroblast|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 4.99e-11 | 161 | 19 | 6 | 6079de6cc4f2aec4091d0fac531fda9a441a70b1 | |
| ToppCell | lung-Club_Cells|lung / shred on tissue and cell subclass | 5.58e-11 | 164 | 19 | 6 | b12cacd499b18b96120ca6d14646aebeaed41d10 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 9.90e-15 | 50 | 11 | 7 | GAVISH_3CA_MALIGNANT_METAPROGRAM_39_METAL_RESPONSE | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 3.37e-12 | 50 | 11 | 6 | GAVISH_3CA_METAPROGRAM_FIBROBLASTS_METAL_RESPONSE | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 1.33e-07 | 50 | 11 | 4 | GAVISH_3CA_METAPROGRAM_EPITHELIAL_METABOLISM_KIDNEY_1 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 1.33e-07 | 50 | 11 | 4 | GAVISH_3CA_METAPROGRAM_ENDOTHELIAL_ENDO_3 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 1.33e-07 | 50 | 11 | 4 | GAVISH_3CA_METAPROGRAM_ENDOTHELIAL_ENDO_7 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 1.33e-07 | 50 | 11 | 4 | GAVISH_3CA_METAPROGRAM_MACROPHAGES_MES_GLYCOLYSIS | |
| Computational | Metal / Ca ion binding. | 6.91e-06 | 133 | 11 | 4 | MODULE_324 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 1.52e-05 | 50 | 11 | 3 | GAVISH_3CA_METAPROGRAM_FIBROBLASTS_CAF_5 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 1.52e-05 | 50 | 11 | 3 | GAVISH_3CA_METAPROGRAM_EPITHELIAL_EMT_LIKE_1 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 1.52e-05 | 50 | 11 | 3 | GAVISH_3CA_MALIGNANT_METAPROGRAM_25_ASTROCYTES | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 1.14e-03 | 50 | 11 | 2 | GAVISH_3CA_METAPROGRAM_FIBROBLASTS_HYPOXIA | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 1.14e-03 | 50 | 11 | 2 | GAVISH_3CA_METAPROGRAM_EPITHELIAL_PDAC_RELATED_3 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 1.14e-03 | 50 | 11 | 2 | GAVISH_3CA_MALIGNANT_METAPROGRAM_METAPROGRAM_6_HYPOXIA | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 1.14e-03 | 50 | 11 | 2 | GAVISH_3CA_MALIGNANT_METAPROGRAM_18_INTERFERON_MHC_II_2 | |
| Computational | B-cell malignancies expression clusters. | 1.91e-03 | 65 | 11 | 2 | MODULE_291 | |
| Computational | Genes in the cancer module 241. | 2.40e-03 | 73 | 11 | 2 | MODULE_241 | |
| Computational | Genes in the cancer module 174. | 4.04e-03 | 95 | 11 | 2 | MODULE_174 | |
| Computational | Genes in the cancer module 321. | 5.57e-03 | 112 | 11 | 2 | MODULE_321 | |
| Drug | MeOBGDTC | 1.12e-27 | 11 | 19 | 9 | CID000119173 | |
| Drug | alpha-mercapto-beta-(2-furyl)acrylic acid | 1.46e-26 | 13 | 19 | 9 | CID006437871 | |
| Drug | diamsar | 4.08e-26 | 14 | 19 | 9 | CID000146286 | |
| Drug | Cadmium-thionein | 4.08e-26 | 14 | 19 | 9 | CID000198548 | |
| Drug | Oral-Turinabol | 7.52e-26 | 27 | 19 | 10 | CID000098521 | |
| Drug | MT45 | 1.02e-25 | 15 | 19 | 9 | CID000431865 | |
| Drug | urs-12-ene-3beta,28-diol | 1.02e-25 | 15 | 19 | 9 | CID000092802 | |
| Drug | ZnATP | 4.95e-25 | 17 | 19 | 9 | CID006455240 | |
| Drug | bismuth nitrate | 4.95e-25 | 17 | 19 | 9 | CID000107711 | |
| Drug | azelaic bishydroxamic acid | 4.95e-25 | 17 | 19 | 9 | CID000065268 | |
| Drug | AC1O3QMZ | 1.88e-24 | 19 | 19 | 9 | CID006334573 | |
| Drug | cadmium oxide | 5.97e-24 | 21 | 19 | 9 | CID000014782 | |
| Drug | 4-(2-pyridylazo)resorcinol | 1.01e-23 | 22 | 19 | 9 | CID005370169 | |
| Drug | zinc hydroxide | 1.01e-23 | 22 | 19 | 9 | CID000062742 | |
| Drug | manganese sulfate monohydrate | 1.66e-23 | 23 | 19 | 9 | CID000166832 | |
| Drug | hinokitiol | 4.15e-23 | 25 | 19 | 9 | CID000003611 | |
| Drug | MT20 | 6.34e-23 | 26 | 19 | 9 | CID003025942 | |
| Drug | BGDTC | 6.34e-23 | 26 | 19 | 9 | CID000105107 | |
| Drug | dimethylmercury | 1.40e-22 | 52 | 19 | 10 | CID000011645 | |
| Drug | Ormaplatino | 4.08e-22 | 31 | 19 | 9 | CID006434704 | |
| Drug | alpha-hederin | 5.68e-22 | 32 | 19 | 9 | CID000073296 | |
| Drug | Zinquin | 7.80e-22 | 33 | 19 | 9 | CID000132933 | |
| Drug | rhodanine | 1.06e-21 | 34 | 19 | 9 | CID001201546 | |
| Drug | p-hydroxyphenyllactic acid | 1.90e-21 | 36 | 19 | 9 | CID000009378 | |
| Drug | dicarboxymethyldithiocarbamate | 2.88e-21 | 9 | 19 | 7 | CID000130472 | |
| Drug | CAPSO-DTC | 2.88e-21 | 9 | 19 | 7 | CID003081023 | |
| Drug | genistin | 3.29e-21 | 38 | 19 | 9 | CID005281377 | |
| Drug | arsenic(III | 5.52e-21 | 40 | 19 | 9 | CID000104734 | |
| Drug | bismuth | 8.99e-21 | 42 | 19 | 9 | CID000105143 | |
| Drug | 2-(chloromethyl)-4-methoxy-3,5-dimethylpyridine | 9.60e-21 | 10 | 19 | 7 | CID000819992 | |
| Drug | PmMT | 9.60e-21 | 10 | 19 | 7 | CID000085248 | |
| Drug | trans-DDP | 1.43e-20 | 44 | 19 | 9 | CID000084691 | |
| Drug | AC1L45V9 | 1.78e-20 | 45 | 19 | 9 | CID000151205 | |
| Drug | trien | 2.22e-20 | 46 | 19 | 9 | CID000005565 | |
| Drug | CAP-N-DTC | 2.64e-20 | 11 | 19 | 7 | CID000125337 | |
| Drug | midodrine | 2.74e-20 | 47 | 19 | 9 | CID000004195 | |
| Drug | octachloronaphthalene | 2.74e-20 | 47 | 19 | 9 | CID000016692 | |
| Drug | dimercaprol | 3.37e-20 | 48 | 19 | 9 | CID000003080 | |
| Drug | DL-propargylglycine | 3.37e-20 | 48 | 19 | 9 | CID000095575 | |
| Drug | oleanolic acid | 7.39e-20 | 52 | 19 | 9 | CID000010494 | |
| Drug | auranofin | 7.39e-20 | 52 | 19 | 9 | CID006918453 | |
| Drug | CdCl2 | 1.22e-19 | 98 | 19 | 10 | CID000024947 | |
| Drug | zinc superoxide | 3.35e-19 | 108 | 19 | 10 | CID000014809 | |
| Drug | tetrathiomolybdate | 3.47e-19 | 61 | 19 | 9 | CID005245480 | |
| Drug | Disperse Blue 7 | 3.47e-19 | 61 | 19 | 9 | CID000018514 | |
| Drug | ZnSO4.7H2O | 4.73e-19 | 63 | 19 | 9 | CID000062639 | |
| Drug | L-beta-aspartyl phosphate | 1.13e-18 | 69 | 19 | 9 | CID000000832 | |
| Drug | zinc sulfate | 1.13e-18 | 69 | 19 | 9 | CID000024424 | |
| Drug | fluoroacetic acid | 1.70e-18 | 72 | 19 | 9 | CID000005236 | |
| Drug | ursolic acid | 1.70e-18 | 72 | 19 | 9 | CID000064945 | |
| Drug | Fe-NTA | 1.93e-18 | 73 | 19 | 9 | CID000027880 | |
| Drug | 6-aminonicotinamide | 2.57e-18 | 39 | 19 | 8 | CID000009500 | |
| Drug | 1q1g | 2.57e-18 | 39 | 19 | 8 | CID000447992 | |
| Drug | selenium | 4.60e-18 | 80 | 19 | 9 | CID006326970 | |
| Drug | 4-(2-pyridylazo)resorcinol | 9.26e-18 | 21 | 19 | 7 | CID000104300 | |
| Drug | acetylbetulinic acid | 1.13e-17 | 88 | 19 | 9 | CID000289984 | |
| Drug | CuSO4 | 1.72e-17 | 92 | 19 | 9 | CID000024462 | |
| Drug | S-nitrosocysteine | 1.90e-17 | 93 | 19 | 9 | CID003359494 | |
| Drug | iproplatin | 1.95e-17 | 23 | 19 | 7 | CID003034746 | |
| Drug | XK234 | 3.00e-17 | 167 | 19 | 10 | CID000454923 | |
| Drug | rutin | 3.10e-17 | 98 | 19 | 9 | CID005280805 | |
| Drug | TPEN | 3.75e-17 | 100 | 19 | 9 | CID000005519 | |
| Drug | diethyldithiocarbamate | 4.11e-17 | 101 | 19 | 9 | CID000008987 | |
| Drug | p-terphenyl | 4.94e-17 | 103 | 19 | 9 | CID000007115 | |
| Drug | fluconazole | 7.04e-17 | 107 | 19 | 9 | CID000003365 | |
| Drug | Zinc chromate hydroxide | 1.24e-16 | 29 | 19 | 7 | CID000027567 | |
| Drug | thiobarbituric acid | 1.75e-16 | 118 | 19 | 9 | CID002723628 | |
| Drug | NiCl2 | 1.89e-16 | 119 | 19 | 9 | CID000024385 | |
| Drug | azathioprine | 2.04e-16 | 120 | 19 | 9 | CID000002265 | |
| Drug | isopropanol | 2.38e-16 | 122 | 19 | 9 | CID000003776 | |
| Drug | AC1L1Z2L | 2.57e-16 | 123 | 19 | 9 | CID000012201 | |
| Drug | zinc acetate dihydrate | 3.38e-16 | 33 | 19 | 7 | CID000636168 | |
| Drug | DEDTC | 4.26e-16 | 34 | 19 | 7 | CID000032064 | |
| Drug | Organoselenium Compounds | 4.38e-16 | 71 | 19 | 8 | ctd:D016566 | |
| Drug | arsenate | 6.07e-16 | 135 | 19 | 9 | CID000000233 | |
| Drug | acrolein | 6.50e-16 | 136 | 19 | 9 | CID000007847 | |
| Drug | DL-penicillamine | 7.95e-16 | 139 | 19 | 9 | CID000004727 | |
| Drug | methylcyclopentadienyl)manganese tricarbonyl | 8.14e-16 | 37 | 19 | 7 | CID005150494 | |
| Drug | cerium | 1.21e-15 | 39 | 19 | 7 | CID000008762 | |
| Drug | motexafin gadolinium | 1.25e-15 | 146 | 19 | 9 | ctd:C437683 | |
| Drug | vanadium | 1.51e-15 | 149 | 19 | 9 | CID000023990 | |
| Drug | zinc chloride | 1.53e-15 | 378 | 19 | 11 | ctd:C016837 | |
| Drug | lead compounds | 1.60e-15 | 150 | 19 | 9 | CID000073212 | |
| Drug | tolmetin glucuronide | 1.73e-15 | 17 | 19 | 6 | ctd:C056583 | |
| Drug | 5,5'-dithiobis(2-nitrobenzoic acid | 2.44e-15 | 157 | 19 | 9 | CID000006254 | |
| Drug | zomepirac glucuronide | 2.59e-15 | 18 | 19 | 6 | ctd:C027368 | |
| Drug | dihydrochloride | 2.73e-15 | 159 | 19 | 9 | CID000070978 | |
| Drug | arsenic | 4.54e-15 | 274 | 19 | 10 | CID005359596 | |
| Drug | neutral red | 4.95e-15 | 47 | 19 | 7 | CID000011105 | |
| Drug | silver nanoparticles | 5.62e-15 | 172 | 19 | 9 | CID000023954 | |
| Drug | sarcolysin | 5.62e-15 | 172 | 19 | 9 | CID000004053 | |
| Drug | 1,1'-azobis(N,N-dimethylformamide | 5.92e-15 | 173 | 19 | 9 | CID000004278 | |
| Drug | selenide ion | 7.69e-15 | 178 | 19 | 9 | CID000107674 | |
| Drug | molybdenum | 8.95e-15 | 181 | 19 | 9 | CID000023932 | |
| Drug | platinum | 9.90e-15 | 183 | 19 | 9 | CID000023939 | |
| Drug | bis-N,N-dimethylamino-2-(N-methylpyrrolyl)methyl cyclopentadienyl titanium (IV) | 1.04e-14 | 104 | 19 | 8 | ctd:C551172 | |
| Drug | zinc chloride (ZnCl2 | 1.15e-14 | 186 | 19 | 9 | CID000005727 | |
| Drug | Ridauran | 1.59e-14 | 55 | 19 | 7 | CID006333887 | |
| Drug | nitrilotriacetic acid | 2.23e-14 | 200 | 19 | 9 | CID000008758 | |
| Drug | CH3Hg | 3.02e-14 | 60 | 19 | 7 | CID000007905 | |
| Disease | median neuropathy (biomarker_via_orthology) | 2.71e-24 | 14 | 16 | 8 | DOID:571 (biomarker_via_orthology) | |
| Disease | retinitis pigmentosa (biomarker_via_orthology) | 5.08e-21 | 13 | 16 | 7 | DOID:10584 (biomarker_via_orthology) | |
| Disease | kidney failure (biomarker_via_orthology) | 1.49e-19 | 19 | 16 | 7 | DOID:1074 (biomarker_via_orthology) | |
| Disease | Alzheimer's disease (biomarker_via_orthology) | 8.79e-16 | 58 | 16 | 7 | DOID:10652 (biomarker_via_orthology) | |
| Disease | transient cerebral ischemia (biomarker_via_orthology) | 6.66e-15 | 157 | 16 | 8 | DOID:224 (biomarker_via_orthology) | |
| Disease | psychotic disorder (is_marker_for) | 2.76e-07 | 2 | 16 | 2 | DOID:2468 (is_marker_for) | |
| Disease | sleep duration, high density lipoprotein cholesterol measurement | 3.62e-05 | 121 | 16 | 3 | EFO_0004612, EFO_0005271 | |
| Disease | Bladder Neoplasm | 5.60e-05 | 140 | 16 | 3 | C0005695 | |
| Disease | Malignant neoplasm of urinary bladder | 5.71e-05 | 141 | 16 | 3 | C0005684 | |
| Disease | Liver carcinoma | 1.33e-04 | 507 | 16 | 4 | C2239176 | |
| Disease | free cholesterol to total lipids in large VLDL percentage | 1.82e-04 | 37 | 16 | 2 | EFO_0022281 | |
| Disease | triglycerides to total lipids in large VLDL percentage | 2.02e-04 | 39 | 16 | 2 | EFO_0022332 | |
| Disease | Respiratory Distress Syndrome, Adult | 4.03e-04 | 55 | 16 | 2 | C0035222 | |
| Disease | protein-glutamine gamma-glutamyltransferase e measurement | 4.79e-04 | 60 | 16 | 2 | EFO_0020690 | |
| Disease | apolipoprotein A 1 measurement | 9.35e-04 | 848 | 16 | 4 | EFO_0004614 | |
| Disease | sexual dimorphism measurement | 2.49e-03 | 1106 | 16 | 4 | EFO_0021796 | |
| Disease | eosinophilic esophagitis | 3.46e-03 | 163 | 16 | 2 | EFO_0004232 | |
| Disease | high density lipoprotein particle size measurement | 3.76e-03 | 170 | 16 | 2 | EFO_0008592 | |
| Disease | Neoplasm Invasiveness | 4.38e-03 | 184 | 16 | 2 | C0027626 | |
| Disease | triglycerides:total lipids ratio, high density lipoprotein cholesterol measurement | 5.46e-03 | 206 | 16 | 2 | EFO_0004612, EFO_0020947 | |
| Disease | cholesterol:total lipids ratio, high density lipoprotein cholesterol measurement | 9.59e-03 | 276 | 16 | 2 | EFO_0004612, EFO_0020943 | |
| Disease | free cholesterol:total lipids ratio, high density lipoprotein cholesterol measurement | 1.15e-02 | 303 | 16 | 2 | EFO_0004612, EFO_0020945 | |
| Disease | cholesteryl ester measurement, high density lipoprotein cholesterol measurement | 1.21e-02 | 312 | 16 | 2 | EFO_0004612, EFO_0010351 | |
| Disease | total cholesterol measurement, high density lipoprotein cholesterol measurement | 1.24e-02 | 315 | 16 | 2 | EFO_0004574, EFO_0004612 | |
| Disease | free cholesterol measurement, high density lipoprotein cholesterol measurement | 1.24e-02 | 315 | 16 | 2 | EFO_0004612, EFO_0008591 | |
| Disease | phospholipid measurement, high density lipoprotein cholesterol measurement | 1.28e-02 | 321 | 16 | 2 | EFO_0004612, EFO_0004639 | |
| Disease | lipid measurement, high density lipoprotein cholesterol measurement | 1.35e-02 | 330 | 16 | 2 | EFO_0004529, EFO_0004612 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| CKECKCTSCKKSCCS | 21 | Q8N339 | |
| CKKCKCTSCKKSCCS | 21 | P0DM35 | |
| CKKCKCTSCKKSCCS | 21 | P80294 | |
| VSSCCKPQCCQSMCC | 81 | Q9BYQ6 | |
| CKECKCTSCKKSCCS | 21 | P04732 | |
| KCEGCKCTSCKKSCC | 21 | P25713 | |
| KCTSCKKSCCSCCPA | 26 | P25713 | |
| KKSCCSCCPAECEKC | 31 | P25713 | |
| CKECKCTSCKKSCCS | 21 | P80297 | |
| CKECKCTSCKKSCCS | 21 | P02795 | |
| SCCVSVCCKPVCCKS | 181 | P60368 | |
| ISSCCRPSCCMSSCC | 81 | Q9BYR0 | |
| RPSCCMSSCCKPQCC | 86 | Q9BYR0 | |
| MSSCCKPQCCQSVCC | 91 | Q9BYR0 | |
| CKPSCSQSSCCKPCC | 151 | Q6L8H2 | |
| SSCCKPYCCQSSCCK | 176 | Q701N2 | |
| SSCCKPYCCQSSCCK | 186 | Q701N2 | |
| KPCCSQSSCCKPCSC | 111 | O75690 | |
| SSCCKPCCSQSSCCK | 136 | O75690 | |
| CKECKCTSCKKSCCS | 21 | P04733 | |
| CKECKCTSCKKSCCS | 21 | P04731 | |
| CTSCKKSCCSCCPMS | 26 | P04731 | |
| KSCCSCCPMSCAKCA | 31 | P04731 | |
| CKECKCTSCKKCCCS | 21 | P07438 | |
| CTSCKKNCCSCCPMG | 26 | A1L3X4 | |
| KNCCSCCPMGCAKCA | 31 | A1L3X4 | |
| ASSCKCKECKCTSCK | 16 | Q93083 | |
| CKECKCTSCKKSCCS | 21 | Q93083 | |
| CTSCKKSCCSCCPMG | 26 | Q93083 | |
| KSCCSCCPMGCAKCA | 31 | Q93083 | |
| CASSCKCKECKCTSC | 16 | P13640 | |
| KCTSCKKSCCSCCPV | 26 | P13640 | |
| KKSCCSCCPVGCAKC | 31 | P13640 |